<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38701081</article-id><article-id pub-id-type="pmc">11095738</article-id>
<article-id pub-id-type="doi">10.1371/journal.pgen.1011268</article-id><article-id pub-id-type="publisher-id">PGENETICS-D-23-01080</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Single Nucleotide Polymorphisms</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Genome-Wide Association Studies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Genome-Wide Association Studies</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Human Genetics</subject><subj-group><subject>Genome-Wide Association Studies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetic Loci</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Genome Analysis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genome Analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Reproductive Physiology</subject><subj-group><subject>Copulation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Genome Annotation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Genome Annotation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma</article-title><alt-title alt-title-type="running-head">Sexual factors and uterine leiomyoma</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6856-0520</contrib-id><name><surname>Wu</surname><given-names>Xueyao</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xiao</surname><given-names>Changfeng</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7715-1809</contrib-id><name><surname>Rasooly</surname><given-names>Danielle</given-names></name><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Xunying</given-names></name><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Morton</surname><given-names>Cynthia Casson</given-names></name><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff006" ref-type="aff">
<sup>6</sup>
</xref><xref rid="aff007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Jiang</surname><given-names>Xia</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff008" ref-type="aff">
<sup>8</sup>
</xref><xref rid="aff009" ref-type="aff">
<sup>9</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0001-4657-3918</contrib-id><name><surname>Gallagher</surname><given-names>C. Scott</given-names></name><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff010" ref-type="aff">
<sup>10</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>National Cancer Institute, Rockville, Maryland, United States of America</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Division of Aging, Department of Medicine, Brigham and Women&#x2019;s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Obstetrics and Gynecology, Brigham and Women&#x2019;s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Pathology, Brigham and Women&#x2019;s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Manchester Centre for Audiology and Deafness, Manchester Academic Health Science Center, University of Manchester, Manchester, United Kingdom</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Solna, Stockholm, Sweden</addr-line></aff><aff id="aff009"><label>9</label>
<addr-line>Department of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China</addr-line></aff><aff id="aff010"><label>10</label>
<addr-line>Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Edwards</surname><given-names>Digna Velez</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Vanderbilt University Medical Center, UNITED STATES</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>xia.jiang@ki.se</email> (XJ); <email>cscottgallagher@gmail.com</email> (CSG)</corresp></author-notes><pub-date pub-type="epub"><day>3</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2024</year></pub-date><volume>20</volume><issue>5</issue><elocation-id>e1011268</elocation-id><history><date date-type="received"><day>25</day><month>9</month><year>2023</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>&#xA9; 2024 Wu et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Wu et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pgen.1011268.pdf"/><abstract><p>Age at first sexual intercourse (AFS) and lifetime number of sexual partners (NSP) may influence the pathogenesis of uterine leiomyoma (UL) through their associations with hormonal concentrations and uterine infections. Leveraging summary statistics from large-scale genome-wide association studies conducted in European ancestry for each trait (N<sub>AFS</sub> = 214,547; N<sub>NSP</sub> = 370,711; N<sub>UL</sub> = 302,979), we observed a significant negative genomic correlation for UL with AFS (<italic toggle="yes">r<sub>g</sub></italic> = &#x2013;0.11, <italic toggle="yes">P</italic> = 7.83&#xD7;10<sup>&#x2212;4</sup>), but not with NSP (<italic toggle="yes">r<sub>g</sub></italic> = 0.01, <italic toggle="yes">P</italic> = 0.62). Four specific genomic regions were identified as contributing significant local genetic correlations to AFS and UL, including one genomic region further identified for NSP and UL. Partitioning SNP-heritability with cell-type-specific annotations, a close clustering of UL with both AFS and NSP was identified in immune and blood-related components. Cross-trait meta-analysis revealed 15 loci shared between AFS/NSP and UL, including 7 novel SNPs. Univariable two-sample Mendelian randomization (MR) analysis suggested no evidence for a causal association between genetically predicted AFS/NSP and risk of UL, nor vice versa. Multivariable MR adjusting for age at menarche or/and age at natural menopause revealed a significant causal effect of genetically predicted higher AFS on a lower risk of UL. Such effect attenuated to null when age at first birth was further included. Utilizing participant-level data from the UK Biobank, one-sample MR based on genetic risk scores yielded consistent null findings among both pre-menopausal and post-menopausal females. From a genetic perspective, our study demonstrates an intrinsic link underlying sexual factors (AFS and NSP) and UL, highlighting shared biological mechanisms rather than direct causal effects. Future studies are needed to elucidate the specific mechanisms involved in the shared genetic influences and their potential impact on UL development.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><p>While uterine leiomyoma (UL) is associated with multiple female reproductive characteristics, little is known regarding its relationship with sexual factors including age at first sexual intercourse (AFS) and lifetime number of sexual partners (NSP). In this study, leveraging large-scale summary- and participant-level genetic variation data, we performed a comprehensive genome-wide cross-trait analysis to assess the shared genetic basis, pleiotropic effects, and bidirectional causal relationships between AFS, NSP, and UL. Our findings provide substantial evidence for a considerable overlapping biology, highlighted by significant genetic correlations, clustering of cell-type-specific annotations, and the presence of multiple shared loci across traits. Nevertheless, we did not identify any compelling evidence supporting a direct causal effect of AFS or NSP on UL risk, nor did we observe a plausible causal role of UL in influencing sexual factors. Collectively, our study underscores that the observed shared heritabilities between sexual factors and UL are primarily driven by common biological mechanisms rather than a causal relationship.</p></abstract><funding-group><award-group id="award001"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap>
</funding-source><award-id>HD060530</award-id><principal-award-recipient>
<name><surname>Morton</surname><given-names>Cynthia Casson</given-names></name>
</principal-award-recipient></award-group><funding-statement>Funding to C.C.M. was provided by the U.S. National Institute of Health (NIH)/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, <ext-link xlink:href="https://www.nichd.nih.gov/" ext-link-type="uri">https://www.nichd.nih.gov/</ext-link>) (No. HD060530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="1"/><page-count count="17"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2024-05-15</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The data underlying the results presented in the study are available to researchers upon application to UK Biobank (<ext-link xlink:href="https://www.ukbiobank.ac.uk/" ext-link-type="uri">https://www.ukbiobank.ac.uk/</ext-link>) or are (partially) publicly available summary statistics. GWAS summary statistics for age at first sexual intercourse, lifetime number of sexual partners, and uterine leiomyoma (without 23andMe) are publicly available. To request access to 23andMe GWAS summary statistics, please visit <ext-link xlink:href="https://research.23andme.com/dataset-access/" ext-link-type="uri">https://research.23andme.com/dataset-access/</ext-link>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The data underlying the results presented in the study are available to researchers upon application to UK Biobank (<ext-link xlink:href="https://www.ukbiobank.ac.uk/" ext-link-type="uri">https://www.ukbiobank.ac.uk/</ext-link>) or are (partially) publicly available summary statistics. GWAS summary statistics for age at first sexual intercourse, lifetime number of sexual partners, and uterine leiomyoma (without 23andMe) are publicly available. To request access to 23andMe GWAS summary statistics, please visit <ext-link xlink:href="https://research.23andme.com/dataset-access/" ext-link-type="uri">https://research.23andme.com/dataset-access/</ext-link>.</p></notes></front>
  <body>
    <sec sec-type="intro" id="sec001">
      <title>Introduction</title>
      <p>As a major source of morbidity for females of reproductive age, uterine leiomyoma (UL) has been associated with multiple female reproductive characteristics including parity, age at first or last childbirth, and age at menarche (AAM)[<xref rid="pgen.1011268.ref001" ref-type="bibr">1</xref>,<xref rid="pgen.1011268.ref002" ref-type="bibr">2</xref>]. In contrast, sexual factors such as age at first sexual intercourse (AFS) and lifetime number of sexual partners (NSP) receive little empirical attention, even with a decrease in AFS and an increase in NSP being observed in many contemporary societies [<xref rid="pgen.1011268.ref003" ref-type="bibr">3</xref>&#x2013;<xref rid="pgen.1011268.ref005" ref-type="bibr">5</xref>]. In addition to impacting ovulation and hormonal concentrations [<xref rid="pgen.1011268.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1011268.ref007" ref-type="bibr">7</xref>], sexual factors may expose participants to infectious agents in the uterus [<xref rid="pgen.1011268.ref008" ref-type="bibr">8</xref>,<xref rid="pgen.1011268.ref009" ref-type="bibr">9</xref>]. Therefore, low AFS or high NSP may correlate with alterations in sex hormones and/or an increased susceptibility to uterine infections, both of which have previously been hypothesized to play an etiologic role in UL pathogenesis [<xref rid="pgen.1011268.ref010" ref-type="bibr">10</xref>&#x2013;<xref rid="pgen.1011268.ref014" ref-type="bibr">14</xref>]. Leveraging data from 181 UL-affected females and 133 healthy referents, Pakiz <italic toggle="yes">et al</italic>. (2020) found a significantly decreased risk of multiple UL associated with higher AFS (OR = 0.27, 95% CI = 0.14&#x2013;0.52, 15]. However, results from retrospective studies are susceptible to bias, including confounding, and reverse causality; and no prospective study has been conducted to date to investigate the phenotypic associations between AFS or NSP with UL.</p>
      <p>In the absence of well-designed observational studies, linking phenotypes through genetics may help uncover the intrinsic mechanisms underlying complex traits. Indeed, genetic regulation of UL and sexual factors have been highlighted by discoveries from recent large-scale genome-wide association studies (GWASs). The SNP (single nucleotide polymorphism)-heritabilities of UL, AFS, and NSP have been quantified as 3&#x2013;13% [CI = 2&#x2013;22%] [<xref rid="pgen.1011268.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1011268.ref017" ref-type="bibr">17</xref>], 12~23% [CI = 7&#x2013;28%] [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>], and 13% [CI = 12&#x2013;13%] [<xref rid="pgen.1011268.ref019" ref-type="bibr">19</xref>], suggesting a non-trivial genetic background for each trait. Further, several common loci have been identified, harboring genes related to follicle stimulating hormone (<italic toggle="yes">FSHB</italic>), implantation (<italic toggle="yes">ESR1</italic>), and embryogenesis (<italic toggle="yes">WNT2</italic>, 16,18,19]. These results suggest that sexual factors and UL might be driven by common biology, though the extent and nature of such links remain unclear. Examining the precise roles of AFS and NSP in UL pathogenesis may advance our understanding of the etiology of disease and possibly aid in the prevention of UL.</p>
      <p>Recent advances in statistical genetics have yielded a range of methods, enabling comprehensive genome-wide cross-trait analyses to characterize extensively the shared genetic architecture and causal link across traits [<xref rid="pgen.1011268.ref020" ref-type="bibr">20</xref>]. Here, we applied these methods to perform a large-scale genome-wide cross-trait analysis between sexual factors and UL. Specifically, leveraging large-scale genetic variation data at both the summary and participant levels, we quantified the shared genetic basis, detected pleiotropic effects, and assessed putative bidirectional causal relationships underlying AFS, NSP, and UL. The overall study design is shown in <bold><xref rid="pgen.1011268.g001" ref-type="fig">Fig 1</xref></bold>.</p>
      <fig position="float" id="pgen.1011268.g001">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1011268.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>Overall study design of genome-wide cross-trait analysis.</title>
          <p>GWAS summary statistics for each trait of interest were retrieved from publicly available GWAS(s). A global genetic correlation analysis between sexual factors and uterine leiomyoma was conducted. The estimated global genetic correlation was further dissected at LD-defined regions. Functional annotation analysis within 396 cell-type-specific annotations was conducted on three traits by using genome-wide SNPs. Cross-trait meta-analysis was applied to identify pleiotropic loci, and a comprehensive Mendelian randomization analysis was used to infer putative causal relationships.</p>
        </caption>
        <graphic xlink:href="pgen.1011268.g001" position="float"/>
      </fig>
    </sec>
    <sec sec-type="materials|methods" id="sec002">
      <title>Materials and methods</title>
      <sec id="sec003">
        <title>Ethics statement</title>
        <p>The GWAS summary statistics used in the present study are aggregated level of data which do not contain any personal information. The original GWAS (or participating cohorts) have obtained ethical approval from relevant ethics review committees (e.g., the Department of Sociology, University of Oxford, the Partners HealthCare System Human Research Committee [Women&#x2019;s Health Study/Women&#x2019;s Genome Health Study], the Ethical Committee of the Northern Ostrobothnia Hospital District [Northern Finnish Birth Cohort], the Human Research Ethics Committee at the QIMR Berghofer Medical Research Institute and the Australian Twin Registry [QIMR Berghofer Medical Research Institute], the North West Multi-centre Research Ethics Committee [UK Biobank], Ethical and Independent Review Services [an external institutional review board; 23andMe], and the Institutional Review Boards at Harvard T.H. Chan School of Public Health and Brigham and Women&#x2019;s Hospital [Partners Human Research Committee] [Nurses&#x2019; Health Study II]). UK Biobank received ethical approval from the Research Ethics Committee (reference 11/NW/0382), and all participants provided written informed consent.</p>
      </sec>
      <sec id="sec004">
        <title>GWAS summary data</title>
        <sec id="sec005">
          <title>Sexual factors</title>
          <p>For AFS, we obtained association results from the UK Biobank for 214,547 females of European ancestry [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>]. For NSP, due to the unavailability of formally published sex-specific summary statistics, we obtained association results from the UK Biobank for 370,711 females and males of European ancestry [<xref rid="pgen.1011268.ref019" ref-type="bibr">19</xref>]. AFS and NSP in the UK Biobank were assessed through the questions, &#x201C;What was your age when you first had sexual intercourse? (sexual intercourse includes vaginal, oral, or anal intercourse)&#x201D;, and &#x201C;About how many sexual partners have you had in your lifetime?&#x201D;, respectively. Both GWAS controlled for the top ten genetic principal components, birth year, and sex (in the sex-combined analysis for NSP). Since the GWAS for AFS identified genetic associations unique to each sex (e.g., 2 female-specific lead SNPs which had no effect at all in males), we applied clumping within a 500kb window (<italic toggle="yes">r</italic><sup>2</sup> &gt; 0.02) using female-specific summary data and identified 113 independent index SNPs (<italic toggle="yes">P</italic> &lt; 5 &#xD7; 10<sup>&#x2212;8</sup>). These index SNPs were used as candidate instrumental variables (IVs). For NSP, candidate IVs were determined as the 117 trait-associated (<italic toggle="yes">P</italic> &lt; 5 &#xD7; 10<sup>&#x2212;8</sup>) index SNPs reported by the GWAS. Details on characteristics of IVs are shown in <bold><xref rid="pgen.1011268.s004" ref-type="supplementary-material">S1</xref> and <xref rid="pgen.1011268.s005" ref-type="supplementary-material">S2</xref> Tables</bold>. We also retrieved full set summary statistics of both AFS and NSP for additional analysis.</p>
        </sec>
        <sec id="sec006">
          <title>Uterine Leiomyoma</title>
          <p>For UL, we obtained association results from the hitherto largest GWAS meta-analysis including data from five participating cohorts of the FibroGENE consortium (Women&#x2019;s Genome Health Study [WGHS], Northern Finnish Birth Cohort [NFBC], QIMR Berghofer Medical Research Institute [QIMR], UK Biobank, and 23andMe), comprising 302,979 female individuals (35,474 cases and 267,505 controls) of European ancestry [<xref rid="pgen.1011268.ref016" ref-type="bibr">16</xref>]. UL was determined based on either self-report (via a single question, such as &#x201C;Have you ever been diagnosed with uterine fibroids?&#x201D;) or clinical documentation (e.g., hospital-linked medical records). For cohorts in which information regarding previous hysterectomy was collected, females with a history of hysterectomy were excluded. Age, genetic relatedness, and body mass index were adjusted for in the association analyses. Top-associated SNPs in the meta-analysis reaching genome-wide significance (<italic toggle="yes">P</italic> &lt; 5 &#xD7; 10<sup>&#x2212;8</sup>) were reported. We extracted relevant information for the 27 UL-associated autosomal SNPs and used those SNPs as IVs. Details on characteristics of the UL-associated IVs are shown in <bold><xref rid="pgen.1011268.s006" ref-type="supplementary-material">S3 Table</xref></bold>. We also retrieved full summary statistics for UL GWAS (with the inclusion of data from 23andMe).</p>
          <p>A table summarizing the information of each included GWAS is shown as <bold><xref rid="pgen.1011268.s007" ref-type="supplementary-material">S4 Table</xref></bold>. For all analyses, the human reference genome build 37 (hg19) was used.</p>
        </sec>
      </sec>
      <sec id="sec007">
        <title>Statistical analysis</title>
        <sec id="sec008">
          <title>Global genetic correlation analysis</title>
          <p>We applied linkage-disequilibrium score regression (LDSC) [<xref rid="pgen.1011268.ref021" ref-type="bibr">21</xref>] to estimate genome-wide genetic correlation aggregating effects of all SNPs, including those that do not reach genome-wide significance. LDSC quantifies the average sharing of genetic effect between two traits with the merits of using only GWAS summary statistics and is not biased by sample overlap. The estimate ranges between &#x2212;1 and +1, with +1 indicating a perfect positive correlation and &#x2212;1 indicating a perfect negative correlation. A Bonferroni-corrected <italic toggle="yes">P</italic>-value threshold of 0.05/2 (number of sexual factors tested) was used to define statistical significance.</p>
        </sec>
        <sec id="sec009">
          <title>Local genetic correlation analysis</title>
          <p>We further used SUPERGNOVA [<xref rid="pgen.1011268.ref022" ref-type="bibr">22</xref>] to detect local genetic correlation under the consideration that even with the absence of global genomic correlation, there might be specific regions in the genome contributing to both traits. SUPERGNOVA applies an algorithm that partitions the whole genome into 2,353 LD-independent regions with an average length of 1.6 centimorgans and quantifies pairwise local genetic correlation contributed by genetic variation at each genomic region. A Bonferroni-corrected <italic toggle="yes">P</italic>-value threshold of 0.05/2,353 was used to represent statistical significance.</p>
        </sec>
        <sec id="sec010">
          <title>Cell-type-specific enrichment analysis</title>
          <p>To gain an overall impression of the relationship among sexual factors and UL, we partitioned the SNP-heritability of each trait using stratified-LDSC [<xref rid="pgen.1011268.ref023" ref-type="bibr">23</xref>] based on cell-type-specific annotations and detected their clustering patterns. A total of 396 cell-type-specific annotations covering six histone marks (DNase, H3K27ac, H3K36me3, H3K4me1, H3K4me3, and H3K9ac) generated by the Roadmap Epigenomics project were used [<xref rid="pgen.1011268.ref024" ref-type="bibr">24</xref>], which were further divided into 9 broad groups, namely adipose, central nervous system, digestive system, cardiovascular, musculoskeletal and connective tissue, immune and blood, liver, pancreas, and other. Enrichment values were transformed into color scale and visualized by hierarchical clustering. A Bonferroni-corrected <italic toggle="yes">P</italic>-threshold (<italic toggle="yes">P</italic> &lt; 0.05/396) was used to define statistical significance.</p>
        </sec>
        <sec id="sec011">
          <title>Cross-trait meta-analysis</title>
          <p>Shared genetic components could be consistent with either genetic variants having independent effect on both traits (i.e., &#x201C;pleiotropy&#x201D;) or genetic variants influencing one trait via its effect on the other (i.e., &#x201C;causality&#x201D;) [<xref rid="pgen.1011268.ref020" ref-type="bibr">20</xref>]. We next performed a cross-trait meta-analysis using Cross-Phenotype Association (CPASSOC) [<xref rid="pgen.1011268.ref025" ref-type="bibr">25</xref>] to identify pleiotropic loci affecting both traits. CPASSOC offers two test statistics, S<sub>Hom</sub> and S<sub>Het</sub>. While S<sub>Hom</sub> is efficient for homogenous genetic effects, S<sub>Het</sub> is an extension of S<sub>Hom</sub> aiming to account for heterogeneity among genetic effects which is more common in practice. Therefore, S<sub>Het</sub> was used in the current study.</p>
          <p>We applied PLINK&#x2019;s &#x201C;clumping&#x201D; function [<xref rid="pgen.1011268.ref026" ref-type="bibr">26</xref>] to obtain independent loci (parameters:&#x2014;clump-p1 5e-8&#x2014;clump-p2 1e-5&#x2014;clump-r2 0.2&#x2014;clump-kb 500). Within each locus, the variant with the lowest <italic toggle="yes">P</italic>-value was kept as the index SNP. Significant pleiotropic SNPs were defined as index variants satisfying both <italic toggle="yes">P</italic><sub>CPASSOC</sub> &lt; 5&#xD7;10<sup>&#x2212;8</sup> and <italic toggle="yes">P</italic><sub>single-trait</sub> &lt; 1&#xD7;10<sup>&#x2212;3</sup> (for both traits). Novel pleiotropic SNPs were defined as significant pleiotropic SNPs that did not reach genome-wide significance in single-trait GWASs (5&#xD7;10<sup>&#x2212;8</sup> &lt; <italic toggle="yes">P</italic><sub>single-trait</sub> &lt; 1&#xD7;10<sup>&#x2212;3</sup>), were independent (<italic toggle="yes">r</italic><sup>2</sup> &lt; 0.20) of previously reported genome-wide significant SNPs (of sexual factors and UL), and had no neighboring SNPs (&#xB1; 500 kb) reaching <italic toggle="yes">P</italic> &lt; 5&#xD7;10<sup>&#x2212;8</sup> in single-trait GWASs.</p>
          <p>We used Ensembl Variant Effect Predictor (VEP) [<xref rid="pgen.1011268.ref027" ref-type="bibr">27</xref>] and 3DSNP [<xref rid="pgen.1011268.ref028" ref-type="bibr">28</xref>] for detailed functional annotation of the identified pleiotropic SNPs.</p>
        </sec>
        <sec id="sec012">
          <title>Two-sample Mendelian randomization analysis</title>
          <p>We performed a bidirectional two-sample Mendelian randomization (MR) analysis to evaluate causal relationships between sexual factors and UL. The random- or fixed-effect inverse-variance weighted (IVW) method was applied as our primary approach [<xref rid="pgen.1011268.ref029" ref-type="bibr">29</xref>]. This method pools the estimate from each IV and provides an overall estimate of the causal effect assuming all IVs to be valid; or are invalid in such a way that the overall pleiotropy is balanced to be zero. Valid IVs must satisfy three core MR assumptions [<xref rid="pgen.1011268.ref030" ref-type="bibr">30</xref>]: (1) the IV is associated with the exposure of interest, (2) there are no confounders of the association between IV and outcome, and (3) the IV affects the outcome only through the effect on the exposure. To assess plausibility of the first assumption, we measured the strength of each instrument by calculating the <italic toggle="yes">F</italic>-statistic using the formula, <inline-formula id="pgen.1011268.e001"><alternatives><graphic xlink:href="pgen.1011268.e001.jpg" id="pgen.1011268.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mi>&#x2010;</mml:mi><mml:mi>K</mml:mi><mml:mi>&#x2010;</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x2212;</mml:mo><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula>, where <italic toggle="yes">R</italic><sup>2</sup> is the proportion of the variability of the trait explained by each instrument, <italic toggle="yes">N</italic> is the GWAS sample size, and <italic toggle="yes">k</italic> is the number of instruments. IVs with <italic toggle="yes">F</italic>-statistic below 10 denote the presence of weak instrument bias [<xref rid="pgen.1011268.ref031" ref-type="bibr">31</xref>], and were therefore removed from further analyses. Additional sensitivity analyses were conducted to evaluate the second and third MR assumptions, including: (i) MR-Egger regression [<xref rid="pgen.1011268.ref032" ref-type="bibr">32</xref>] to detect and correct for bias due to directional pleiotropy; (ii) weighted median approach [<xref rid="pgen.1011268.ref033" ref-type="bibr">33</xref>] which provides a consistent estimate of the causal effect even when up to 50% of genetic variants are invalid; (iii) exclusion of palindromic IVs with strand ambiguity; (iv) an assessment of heterogeneity using Cochran&#x2019;s <italic toggle="yes">Q</italic>-statistic, where a <italic toggle="yes">P</italic>-value &lt; 0.05 indicates the presence of heterogeneity and thus a random-effect IVW approach was used; and (v) exclusion of index SNPs with pleiotropic associations (<italic toggle="yes">P</italic>-value &lt; 5&#xD7;10<sup>&#x2212;8</sup>) with potential confounding traits (<bold><xref rid="pgen.1011268.s004" ref-type="supplementary-material">S1</xref>, <xref rid="pgen.1011268.s005" ref-type="supplementary-material">S2</xref>, and <xref rid="pgen.1011268.s006" ref-type="supplementary-material">S3</xref> Tables</bold>) as confirmed by GWAS Catalog [<xref rid="pgen.1011268.ref034" ref-type="bibr">34</xref>], and index SNPs identified by the cross-trait meta-analysis to be shared between sexual factors and UL.</p>
          <p>For causal estimates that showed directional consistency across primary approach and sensitivity analyses, we further applied an IVW-based multivariable MR (MVMR) approach to adjust for any potential confounding effects (which might have masked or inflated the true causal associations) acting through AAM [<xref rid="pgen.1011268.ref035" ref-type="bibr">35</xref>], age at natural menopause (ANM) [<xref rid="pgen.1011268.ref036" ref-type="bibr">36</xref>], and age at first birth (AFB) [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>], factors that are known to affect the lifelong exposure of a woman to steroid sex hormones. Following MVMR, a mediation analysis within a two-step MR framework was performed to explore the potential mediating effects of various hormone-related phenotypes in the sexual factors-UL relationships (<bold><xref rid="pgen.1011268.s002" ref-type="supplementary-material">S1 Fig</xref></bold>). Detailed methods can be found in <bold><xref rid="pgen.1011268.s001" ref-type="supplementary-material">S1 Text</xref></bold>. Given the prevalence of approximately 4 percent of ultrasound-identified UL occurs in females aged 20 to 30 years [<xref rid="pgen.1011268.ref037" ref-type="bibr">37</xref>], there is a possibility that UL may affect subsequent sexual behaviors. We therefore conducted a reverse-direction MR to evaluate the putative causal effect of genetic liability to UL on sexual factors using UL-associated independent SNPs as IVs.</p>
          <p>Two-sample MR analyses were conducted using packages &#x201C;TwoSampleMR&#x201D; (v0.5.4) and &#x201C;MendelianRandomization&#x201D; (v0.7.0) in software R (v4.1.0).</p>
        </sec>
        <sec id="sec013">
          <title>Supplementary MR analysis</title>
          <p>To assess the robustness of findings from the two-sample MR, particularly in relation to different menopausal status, we undertook supplementary one-sample MR analysis utilizing participant-level data obtained from the UK Biobank.</p>
          <p>In brief, UK Biobank is a large-scale prospective study that recruited 502,536 participants aged 37&#x2013;73 years between 2006 and 2010 [<xref rid="pgen.1011268.ref038" ref-type="bibr">38</xref>]. To align with our primary genetic analyses, we focused exclusively on a subset of 257,414 females of European descent. During the initial visit, participants completed touch-screen questionnaires to provide information on sexual factors, and blood samples were collected for genotyping purposes. Detailed information regarding genotyping, imputation, and quality control has been described previously [<xref rid="pgen.1011268.ref038" ref-type="bibr">38</xref>]. For our analysis, a total of 180,494 females who had complete data on sexual factors and imputed genotypes were included. Among these participants, 14,542 were identified as UL cases based on a combination of hospital-linked medical records (ICD-10 code D25 and ICD-9 code 218) and self-report (interview with research nurse).</p>
          <p>The 113 and 117 significantly associated SNPs were utilized to construct genetic risk score (GRS) for AFS and NSP, respectively. To mitigate one-sample bias towards the confounded observational association, we summarized the number of AFS/NSP-increasing alleles to generate the unweighted GRS rather than weighted GRS. A two-stage method was implemented to estimate the causal effect of AFS or NSP on UL risk. The first stage model consisted of a linear regression of AFS/NSP on the allele score and the second stage model consisted of a logistic regression of UL status on the fitted values from the first stage regression, with adjustment for age at recruitment, assessment center, top ten genetic principal components, educational attainment, Townsend deprivation index, AAM, AFB, and history of oral contraceptive pill use or hormone-replacement therapy in both stages. Taking advantage of the participant-level data, we were able to perform separate analyses for pre-menopausal (n = 43,741) and post-menopausal females (n = 108,330). The categorization was based on a single question asked during the baseline assessment: &#x201C;Have you had your menopause (periods stopped)?&#x201D;. Participants could choose from five responses, including &#x201C;Yes&#x201D;, &#x201C;No&#x201D;, &#x201C;Not sure&#x2013;had a hysterectomy&#x201D;, &#x201C;Not sure&#x2013;other reason&#x201D;, and &#x201C;Prefer not to answer&#x201D;. We classified females who responded &#x201C;Yes&#x201D; as post-menopausal, those who responded &#x201C;No&#x201D; as pre-menopausal, and considered other responses as missing values, leading to their exclusion from the analysis. In the subgroup analysis of post-menopausal females, ANM was additionally adjusted.</p>
          <p>A Bonferroni-corrected <italic toggle="yes">P</italic>-value threshold of 0.025 was employed for determining statistical significance in all MR analyses, considering the two sexual factors that were examined.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results" id="sec014">
      <title>Results</title>
      <sec id="sec015">
        <title>Global and local genetic correlation</title>
        <p>Leveraging genome-wide SNP information, we identified a significant negative genomic correlation between AFS and UL (<italic toggle="yes">r<sub>g</sub></italic> = &#x2013;0.11, <italic toggle="yes">P</italic> = 7.83&#xD7;10<sup>&#x2212;4</sup>). No genomic correlation was observed for NSP with UL (<italic toggle="yes">r<sub>g</sub></italic> = 0.01, <italic toggle="yes">P</italic> = 0.62).</p>
        <p>Breaking down the whole genome into 2,353 regions, four genomic regions were identified as contributing significant local genetic correlations to AFS and UL, including 3q27.2&#x2013;27.3 (chr3: 185263467&#x2013;186780913), 5q35.2&#x2013;35.3 (chr5: 176129392&#x2013;177991305), 4q24 (chr4: 103388441&#x2013;104802530), and 5q14.1&#x2013;14.2 (chr5: 80481996&#x2013;81712715) (<bold><xref rid="pgen.1011268.g002" ref-type="fig">Fig 2</xref></bold> and <bold><xref rid="pgen.1011268.s008" ref-type="supplementary-material">S5 Table</xref></bold>). Of note, local signals at 5q35.2&#x2013;35.3 were previously implicated in UL, and 5q14.1&#x2013;14.2 was previously implicated in AFS (assessed in GWAS Catalog on September 21, 2022). While 3q27.2&#x2013;27.3 and 4q24 have not been linked to AFS or UL directly, the former region was reported to associate with AAM, the latter was reported to associate with testosterone measurement. Among the four local signals, 5q35.2&#x2013;35.3 was further identified as shared between NSP and UL (<bold><xref rid="pgen.1011268.g002" ref-type="fig">Fig 2</xref></bold> and <bold><xref rid="pgen.1011268.s009" ref-type="supplementary-material">S6 Table</xref></bold>), despite the negligible global genomic correlation.</p>
        <fig position="float" id="pgen.1011268.g002">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1011268.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Local genetic correlations between uterine leiomyoma and sexual factors.</title>
            <p><bold>(A).</bold> Manhattan plot presenting region-specific <italic toggle="yes">P</italic>-values for local genetic correlation between uterine leiomyoma and age at first sexual intercourse. <bold>(B).</bold> Manhattan plot presenting region-specific <italic toggle="yes">P</italic>-values for local genetic correlation between uterine leiomyoma and lifetime number of sexual partners. Red dots represent loci showing significant local genetic correlation after multiple testing adjustment (<italic toggle="yes">P</italic> &lt; 0.05/2,353). AFS, age at first sexual intercourse; UL, uterine leiomyoma; NSP, lifetime number of sexual partners.</p>
          </caption>
          <graphic xlink:href="pgen.1011268.g002" position="float"/>
        </fig>
      </sec>
      <sec id="sec016">
        <title>Cell-type-specific heritability enrichment</title>
        <p>In addition to region-specific genetic association, we investigated partitioned SNP-heritability enrichment using 396 cell-type-specific annotations. Three specific annotations were identified for UL with Bonferroni-corrected significant enrichment, including fetal heart in H3K9ac and DNase, and rectal smooth muscle in H3K4me1. As for AFS and NSP, they exhibited significant heritability enrichments in 29 and 17 annotations, respectively, all of which were related to the central nervous system (<bold><xref rid="pgen.1011268.s010" ref-type="supplementary-material">S7 Table</xref></bold>). Notably, despite non-significance, we observed a close clustering of UL with both AFS and NSP in immune and blood related components, especially in fetal thymus and primary T cells from cord blood (<bold><xref rid="pgen.1011268.s003" ref-type="supplementary-material">S2 Fig</xref></bold>).</p>
      </sec>
      <sec id="sec017">
        <title>Cross-trait meta-analysis and pleiotropic loci</title>
        <p>Motivated by the significant genetic overlap observed in our global and local heritability analyses, we next sought to detect pleiotropic loci at the variant level. In total, 15 independent loci reached genome-wide significance in CPASSOC (<italic toggle="yes">P</italic><sub>CPASSOC</sub> &lt; 5&#xD7;10<sup>&#x2212;8</sup> and <italic toggle="yes">P</italic><sub>UL</sub> &lt; 1&#xD7;10<sup>&#x2212;3</sup> and <italic toggle="yes">P</italic><sub>AFS/NSP</sub> &lt; 1&#xD7;10<sup>&#x2212;3</sup>), including 10 loci shared between AFS and UL, and 5 loci shared between NSP and UL (<bold><xref rid="pgen.1011268.t001" ref-type="table">Table 1</xref></bold>). Among these pleiotropic loci, SNP rs11031005 was the strongest shared signal (<italic toggle="yes">P</italic><sub>CPASSOC</sub> = 2.20&#xD7;10<sup>&#x2212;17</sup>) identified for AFS and UL, interacting with <italic toggle="yes">FSHB</italic> through three-dimensional chromatin looping [<xref rid="pgen.1011268.ref028" ref-type="bibr">28</xref>]. SNP rs2018458 was the strongest shared signal (<italic toggle="yes">P</italic><sub>CPASSOC</sub> &lt; 1.00&#xD7;10<sup>&#x2212;324</sup>) identified for NSP and UL, located near <italic toggle="yes">TNRC6B</italic> which is a well-known UL risk gene [<xref rid="pgen.1011268.ref016" ref-type="bibr">16</xref>].</p>
        <table-wrap position="float" id="pgen.1011268.t001">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1011268.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Pleiotropic loci identified in cross-trait meta-analysis between sexual factors and uterine leiomyoma (<italic toggle="yes">P</italic><sub>CPASSOC</sub> &lt; 5&#xD7;10<sup>&#x2212;8</sup>, single trait <italic toggle="yes">P</italic>-value &lt;1&#xD7;10<sup>&#x2212;3</sup>).</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pgen.1011268.t001" id="pgen.1011268.t001g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="2" colspan="1">Index SNP</th>
                  <th align="center" rowspan="2" colspan="1">A1/A2</th>
                  <th align="center" colspan="2" rowspan="1">BETA</th>
                  <th align="center" colspan="2" rowspan="1">
<italic toggle="yes">P</italic>
</th>
                  <th align="center" rowspan="2" colspan="1">
<italic toggle="yes">P</italic>
<sub>CPASSOC</sub>
</th>
                  <th align="center" rowspan="2" colspan="1">Genomic coordinates</th>
                  <th align="center" rowspan="2" colspan="1">Linear closest genes<sup>a</sup></th>
                  <th align="center" rowspan="2" colspan="1">Interacting genes<sup>b</sup></th>
                </tr>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Sexual factor</th>
                  <th align="center" rowspan="1" colspan="1">UL</th>
                  <th align="center" rowspan="1" colspan="1">Sexual factor</th>
                  <th align="center" rowspan="1" colspan="1">UL</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" colspan="10" rowspan="1">
<italic toggle="yes">Age at first sexual intercourse and uterine leiomyoma</italic>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs6669189</td>
                  <td align="center" rowspan="1" colspan="1">C/T</td>
                  <td align="center" rowspan="1" colspan="1">0.01</td>
                  <td align="center" rowspan="1" colspan="1">0.03</td>
                  <td align="center" rowspan="1" colspan="1">4.90&#xD7;10<sup>&#x2212;06</sup></td>
                  <td align="center" rowspan="1" colspan="1">3.32&#xD7;10<sup>&#x2212;04</sup></td>
                  <td align="center" rowspan="1" colspan="1">3.22&#xD7;10<sup>&#x2212;08</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr1:74977277&#x2013;75014538</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">TNNI3K</italic>, <italic toggle="yes">FPGT-TNNI3K</italic></td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C1orf173</italic>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs10173592</td>
                  <td align="center" rowspan="1" colspan="1">T/C</td>
                  <td align="center" rowspan="1" colspan="1">-0.01</td>
                  <td align="center" rowspan="1" colspan="1">0.04</td>
                  <td align="center" rowspan="1" colspan="1">1.00&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">3.01&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.15&#xD7;10<sup>&#x2212;09</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr2:202863476&#x2013;202952096</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">FZD7</italic>, <italic toggle="yes">LOC100652824</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs6800916</td>
                  <td align="center" rowspan="1" colspan="1">T/A</td>
                  <td align="center" rowspan="1" colspan="1">0.02</td>
                  <td align="center" rowspan="1" colspan="1">0.14</td>
                  <td align="center" rowspan="1" colspan="1">2.50&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">1.49&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.75&#xD7;10<sup>&#x2212;09</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr3:49970310&#x2013;50435832</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">RBM6</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">MON1A</italic>, <italic toggle="yes">MST1R</italic>, <italic toggle="yes">RBM5</italic>, <italic toggle="yes">RBM6</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs73250917</td>
                  <td align="center" rowspan="1" colspan="1">C/T</td>
                  <td align="center" rowspan="1" colspan="1">-0.01</td>
                  <td align="center" rowspan="1" colspan="1">0.04</td>
                  <td align="center" rowspan="1" colspan="1">2.60&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">5.45&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.27&#xD7;10<sup>&#x2212;08</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr4:53823221&#x2013;53872674</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">SCFD2</italic>, <italic toggle="yes">RP11-752D24</italic>.<italic toggle="yes">2</italic></td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">RASL11B</italic>, <italic toggle="yes">DANCR</italic>, <italic toggle="yes">LOC152578</italic>, <italic toggle="yes">MIR4449</italic>, <italic toggle="yes">SNORA26</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs11031005</td>
                  <td align="center" rowspan="1" colspan="1">T/C</td>
                  <td align="center" rowspan="1" colspan="1">-0.01</td>
                  <td align="center" rowspan="1" colspan="1">0.10</td>
                  <td align="center" rowspan="1" colspan="1">4.20&#xD7;10<sup>&#x2212;04</sup></td>
                  <td align="center" rowspan="1" colspan="1">1.39&#xD7;10<sup>&#x2212;14</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.20&#xD7;10<sup>&#x2212;17</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr11:30125619&#x2013;30395871</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">FSHB</italic>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs2732538</td>
                  <td align="center" rowspan="1" colspan="1">T/A</td>
                  <td align="center" rowspan="1" colspan="1">0.02</td>
                  <td align="center" rowspan="1" colspan="1">0.05</td>
                  <td align="center" rowspan="1" colspan="1">4.40&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">1.57&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">4.60&#xD7;10<sup>&#x2212;09</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr11:35073408&#x2013;35095948</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">CD44</italic>, <italic toggle="yes">MIR1343</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs28583837</td>
                  <td align="center" rowspan="1" colspan="1">G/A</td>
                  <td align="center" rowspan="1" colspan="1">-0.01</td>
                  <td align="center" rowspan="1" colspan="1">-0.06</td>
                  <td align="center" rowspan="1" colspan="1">2.60&#xD7;10<sup>&#x2212;04</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.93&#xD7;10<sup>&#x2212;08</sup></td>
                  <td align="center" rowspan="1" colspan="1">1.31&#xD7;10<sup>&#x2212;11</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr12:123450765&#x2013;123913433</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KMT5A</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">SETD8</italic>, <italic toggle="yes">CDK2AP1</italic>, <italic toggle="yes">RILPL2</italic>, <italic toggle="yes">SBNO1</italic>, <italic toggle="yes">SNRNP35</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs9603689</td>
                  <td align="center" rowspan="1" colspan="1">A/G</td>
                  <td align="center" rowspan="1" colspan="1">0.01</td>
                  <td align="center" rowspan="1" colspan="1">0.04</td>
                  <td align="center" rowspan="1" colspan="1">8.10&#xD7;10<sup>&#x2212;04</sup></td>
                  <td align="center" rowspan="1" colspan="1">5.95&#xD7;10<sup>&#x2212;06</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.72&#xD7;10<sup>&#x2212;08</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr13:40724728&#x2013;40724728</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">LINC00332</italic>, <italic toggle="yes">LINC00548</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs76513770</td>
                  <td align="center" rowspan="1" colspan="1">T/C</td>
                  <td align="center" rowspan="1" colspan="1">-0.02</td>
                  <td align="center" rowspan="1" colspan="1">0.04</td>
                  <td align="center" rowspan="1" colspan="1">8.50&#xD7;10<sup>&#x2212;09</sup></td>
                  <td align="center" rowspan="1" colspan="1">8.35&#xD7;10<sup>&#x2212;04</sup></td>
                  <td align="center" rowspan="1" colspan="1">1.82&#xD7;10<sup>&#x2212;09</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr16:72006370&#x2013;72822296</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">AC004158</italic>.<italic toggle="yes">2</italic></td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs67796606</td>
                  <td align="center" rowspan="1" colspan="1">A/G</td>
                  <td align="center" rowspan="1" colspan="1">-0.02</td>
                  <td align="center" rowspan="1" colspan="1">-0.07</td>
                  <td align="center" rowspan="1" colspan="1">6.00&#xD7;10<sup>&#x2212;06</sup></td>
                  <td align="center" rowspan="1" colspan="1">3.88&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">4.55&#xD7;10<sup>&#x2212;09</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr20:62294045&#x2013;62488635</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">ZBTB46</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">SLC2A4RG</italic>, <italic toggle="yes">ABHD16B</italic>, <italic toggle="yes">ARFRP1</italic>, <italic toggle="yes">DNAJC5</italic>, <italic toggle="yes">LIME1</italic>, <italic toggle="yes">MIR1914</italic>, <italic toggle="yes">MIR647</italic>, <italic toggle="yes">MIR941-1</italic>, <italic toggle="yes">MIR941-2</italic>, <italic toggle="yes">MIR941-3</italic>, <italic toggle="yes">MIR941-4</italic>, <italic toggle="yes">TNFRSF6B</italic>, <italic toggle="yes">TPD52L2</italic>, <italic toggle="yes">UCKL1</italic>, <italic toggle="yes">UCKL1-AS1</italic>, <italic toggle="yes">ZBTB46</italic>, <italic toggle="yes">ZGPAT</italic></td>
                </tr>
                <tr>
                  <td align="left" colspan="10" rowspan="1">
<italic toggle="yes">Lifetime number of sexual partners and uterine leiomyoma</italic>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs6604866</td>
                  <td align="center" rowspan="1" colspan="1">C/G</td>
                  <td align="center" rowspan="1" colspan="1">-0.01</td>
                  <td align="center" rowspan="1" colspan="1">-0.03</td>
                  <td align="center" rowspan="1" colspan="1">3.20&#xD7;10<sup>&#x2212;06</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.28&#xD7;10<sup>&#x2212;04</sup></td>
                  <td align="center" rowspan="1" colspan="1">1.53&#xD7;10<sup>&#x2212;08</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr1:74977277&#x2013;75014538</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">TNNI3K</italic>, <italic toggle="yes">FPGT-TNNI3K</italic></td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C1orf173</italic>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs61830447</td>
                  <td align="center" rowspan="1" colspan="1">A/G</td>
                  <td align="center" rowspan="1" colspan="1">0.01</td>
                  <td align="center" rowspan="1" colspan="1">0.04</td>
                  <td align="center" rowspan="1" colspan="1">2.73&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">6.43&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">3.65&#xD7;10<sup>&#x2212;08</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr10:11134855&#x2013;11166455</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">CELF2</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">CELF2-AS2</italic>, <italic toggle="yes">CELF2</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs5742915</td>
                  <td align="center" rowspan="1" colspan="1">T/C</td>
                  <td align="center" rowspan="1" colspan="1">-0.01</td>
                  <td align="center" rowspan="1" colspan="1">-0.04</td>
                  <td align="center" rowspan="1" colspan="1">1.04&#xD7;10<sup>&#x2212;04</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.02&#xD7;10<sup>&#x2212;06</sup></td>
                  <td align="center" rowspan="1" colspan="1">9.57&#xD7;10<sup>&#x2212;09</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr15:74336633&#x2013;74353561</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">PML</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">LOXL1-AS1</italic>, <italic toggle="yes">GOLGA6A</italic>, <italic toggle="yes">ISLR</italic>, <italic toggle="yes">ISLR2</italic>, <italic toggle="yes">LOC283731</italic>, <italic toggle="yes">LOXL1</italic>, <italic toggle="yes">PML</italic>, <italic toggle="yes">STOML1</italic>, <italic toggle="yes">STRA6</italic></td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs66998222</td>
                  <td align="center" rowspan="1" colspan="1">A/G</td>
                  <td align="center" rowspan="1" colspan="1">0.01</td>
                  <td align="center" rowspan="1" colspan="1">-0.06</td>
                  <td align="center" rowspan="1" colspan="1">2.38&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">4.94&#xD7;10<sup>&#x2212;08</sup></td>
                  <td align="center" rowspan="1" colspan="1">8.34&#xD7;10<sup>&#x2212;11</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr16:51420501&#x2013;51488129</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">SALL1</italic>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">rs2018458</td>
                  <td align="center" rowspan="1" colspan="1">A/C</td>
                  <td align="center" rowspan="1" colspan="1">0.01</td>
                  <td align="center" rowspan="1" colspan="1">-0.05</td>
                  <td align="center" rowspan="1" colspan="1">&lt;1.00&#xD7;10<sup>&#x2212;324</sup></td>
                  <td align="center" rowspan="1" colspan="1">2.28&#xD7;10<sup>&#x2212;05</sup></td>
                  <td align="center" rowspan="1" colspan="1">&lt;1.00&#xD7;10<sup>&#x2212;324</sup></td>
                  <td align="center" rowspan="1" colspan="1">chr22:40429365&#x2013;40539379</td>
                  <td align="center" rowspan="1" colspan="1">
<italic toggle="yes">TNRC6B</italic>
</td>
                  <td align="center" rowspan="1" colspan="1"><italic toggle="yes">LOC100130899</italic>, <italic toggle="yes">FAM83F</italic>, <italic toggle="yes">TNRC6B</italic></td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t001fn001">
              <p>Position is under build 37 (hg19). <sup>a</sup> Linear closest genes of index SNPs were mapped by using VEP. <sup>b</sup> 3D interacting genes of index SNPs were mapped by using 3DSNP.</p>
            </fn>
            <fn id="t001fn002">
              <p>SNP, single nucleotide polymorphisms; UL, uterine leiomyoma.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>After excluding SNPs that were in LD (<italic toggle="yes">r</italic><sup>2</sup> &#x2265; 0.20) with previously reported single-trait-associated significant SNPs, we identified 4 novel SNPs (rs6669189, rs10173592, rs73250917, and rs67796606) shared between AFS and UL. While SNP rs10173592 was located in an intergenic region, it interacts with <italic toggle="yes">FZD7</italic>[<xref rid="pgen.1011268.ref028" ref-type="bibr">28</xref>], a previously reported risk gene for AFS [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>]. SNP rs6669189 was located near <italic toggle="yes">TNNI3K</italic> previously implicated in AAM [<xref rid="pgen.1011268.ref039" ref-type="bibr">39</xref>&#x2013;<xref rid="pgen.1011268.ref041" ref-type="bibr">41</xref>] and AFS [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>]; SNP rs73250917 was located near <italic toggle="yes">SCFD2</italic> previously implicated in UL [<xref rid="pgen.1011268.ref016" ref-type="bibr">16</xref>]; and SNP rs67796606 was harbored in <italic toggle="yes">ZBTB46</italic> previously implicated in AAM [<xref rid="pgen.1011268.ref041" ref-type="bibr">41</xref>] and AFS [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>].</p>
        <p>In addition to rs6604866 (located at the same locus with rs6669189), two novel SNPs (i.e., rs61830447 and rs5742915) were further identified as shared between NSP and UL. SNP rs61830447 was mapped to <italic toggle="yes">CELF2</italic>, a gene previously reported as associated with AFS [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>]; and SNP rs5742915 was located near <italic toggle="yes">PML</italic>, a gene previously reported as associated with AAM [<xref rid="pgen.1011268.ref041" ref-type="bibr">41</xref>].</p>
        <p>Detailed annotations of each index SNP are shown in <bold><xref rid="pgen.1011268.s011" ref-type="supplementary-material">S8 Table</xref></bold>.</p>
      </sec>
      <sec id="sec018">
        <title>Mendelian randomization and causal relationship</title>
        <p>Given the presence of between-IV heterogeneity detected by the Cochran&#x2019;s Q test (AFS to UL: <italic toggle="yes">P</italic><sub>Cochran&#x2019;s Q</sub> = 1.27&#xD7;10<sup>&#x2212;4</sup>; NSP to UL: <italic toggle="yes">P</italic><sub>Cochran&#x2019;s Q</sub> = 9.27&#xD7;10<sup>&#x2212;4</sup>), we used the random-effect IVW as our primary approach. We identified an inverse but non-significant association between genetically predicted AFS and risk of UL (OR = 0.89, 95% CI = 0.79&#x2013;1.01, <italic toggle="yes">P</italic> = 0.06), which remained directionally consistent across the complementary two-sample MR approaches (MR-Egger: OR = 0.99, 95% CI = 0.59&#x2013;1.65, <italic toggle="yes">P</italic> = 0.96; weighted median: OR = 0.95, 95% CI = 0.82&#x2013;1.11, <italic toggle="yes">P</italic> = 0.47; palindromic SNPs excluded: OR = 0.89; 95% CI = 0.78&#x2013;1.01, <italic toggle="yes">P</italic> = 0.06; pleiotropic SNPs excluded: OR = 0.96, 95% CI = 0.84&#x2013;1.10, <italic toggle="yes">P</italic> = 0.58). No sign of association was observed for genetically predicted NSP with UL risk (<bold><xref rid="pgen.1011268.g003" ref-type="fig">Fig 3</xref></bold>). We found little evidence of weak instrument bias (<italic toggle="yes">F</italic>-statistics for AFS 33.3; for NSP 41.0; for UL 883.5).</p>
        <fig position="float" id="pgen.1011268.g003">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1011268.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title>Causal relationships underlying uterine leiomyoma, age at first sexual intercourse, and lifetime number of sexual partners.</title>
            <p><bold>(A).</bold> Estimates of causal effects for genetically predicted age at first sexual intercourse with uterine leiomyoma. <bold>(B).</bold> Estimates of causal effects for genetically predicted lifetime number of sexual partners with uterine leiomyoma. <bold>(C).</bold> Independent effects of genetically predicted age at first sexual intercourse on uterine leiomyoma after adjusting for each potential confounder separately and together using multi-variable Mendelian randomization. <bold>(D).</bold> Estimates of causal effects for genetically predicted uterine leiomyoma with sexual factors (age at first sexual intercourse, lifetime number of sexual partners). Boxes represent the point estimates of causal effects, and error bars represent 95% confidence intervals. AFS, age at first sexual intercourse; UL, uterine leiomyoma; NSP, lifetime number of sexual partners; AFB, age at first birth; AAM, age at menarche; ANM, age at natural menopause.</p>
          </caption>
          <graphic xlink:href="pgen.1011268.g003" position="float"/>
        </fig>
        <p>We further performed MVMR to evaluate the independent effect of AFS while accounting for essential confounders including AAM, ANM, and AFB. As a result, genetically predicted higher AFS was significantly associated with a lower risk of UL after adjusting for AAM (OR = 0.87, 95% CI = 0.78&#x2013;0.98, <italic toggle="yes">P</italic> = 0.02), ANM (OR = 0.87, 95% CI = 0.77&#x2013;0.98, <italic toggle="yes">P</italic> = 0.02), or AAM and ANM together (OR = 0.86, 95% CI = 0.77&#x2013;0.96, <italic toggle="yes">P</italic> = 0.01). Nonetheless, when controlling for the effect of AFB, the AFS-UL association attenuated to null (OR = 1.03, 95% CI = 0.83&#x2013;1.27, <italic toggle="yes">P</italic> = 0.79). Similar null result was generated after adjusting for AAM, ANM, and AFB in combination (OR = 0.99, 95% CI = 0.85&#x2013;1.16, <italic toggle="yes">P</italic> = 0.94) (<bold><xref rid="pgen.1011268.g003" ref-type="fig">Fig 3</xref></bold>). Mediation analysis did not support any hormone-related phenotypes as mediators in the relationship between AFS/NSP and UL. However, significant indirect effects of AFS on UL were observed through several hormone-related phenotypes, including AFB (<bold><xref rid="pgen.1011268.s012" ref-type="supplementary-material">S9 Table</xref></bold>).</p>
        <p>No evidence of reverse causality was found such that genetic liability to UL neither influences AFS (OR = 1.00, 95% CI = 0.98&#x2013;1.02, <italic toggle="yes">P</italic> = 0.92) nor NSP (OR = 1.01, 95% CI = 0.99&#x2013;1.02, <italic toggle="yes">P</italic> = 0.58) (<bold><xref rid="pgen.1011268.g003" ref-type="fig">Fig 3</xref></bold>).</p>
        <p>Corroborating the two-sample MR findings, GRS-based one-sample MR analysis demonstrated no evidence supporting a causal effect of genetically predicted AFS or NSP on risk of UL, consistent among both pre-menopausal and post-menopausal females (OR = 1.00 and <italic toggle="yes">P</italic> &gt; 0.10 across all analyses).</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec019">
      <title>Discussion</title>
      <p>To the best of our knowledge, this is the first large-scale genome-wide cross-trait analysis which comprehensively interrogated the shared genetic architecture between sexual factors and UL. From a genetic perspective, our work demonstrates a biological link between AFS, NSP, and UL that is driven by pleiotropic effects rather than causal relationships.</p>
      <p>Overall, a limited yet statistically significant global genetic similarity was identified between AFS and UL, where ~ 11% of the genetic contribution to AFS is shared with the genetic contribution to UL. The overall genetic correlation was further corroborated by significant local signals identified at multiple specific genomic regions, collectively highlighting a non-trivial shared biological basis. Notably, although we identified the global <italic toggle="yes">r<sub>g</sub></italic> between NSP and UL to be close to zero, subsequent regional analyses revealed a statistically significant, shared local heritability in a genomic region that was previously reported to be independently associated with UL, AAM, and ANM by separate GWASs [<xref rid="pgen.1011268.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1011268.ref017" ref-type="bibr">17</xref>,<xref rid="pgen.1011268.ref042" ref-type="bibr">42</xref>&#x2013;<xref rid="pgen.1011268.ref044" ref-type="bibr">44</xref>]. As such, our results show that global genomic approaches to measuring shared heritability may fail to detect meaningful overlap between association signals locally.</p>
      <p>Through analyzing gene expression data with GWAS summary statistics, our study confirmed previous identifications of a brain cell-type enrichment for both AFS and NSP [<xref rid="pgen.1011268.ref018" ref-type="bibr">18</xref>,<xref rid="pgen.1011268.ref019" ref-type="bibr">19</xref>]. The similar enrichment patterns when partitioning heritability for UL and that of sexual factors further elucidate potential overlapped etiology related to the immune system. A chronically active inflammatory immune system is suggested to be involved in UL formation [<xref rid="pgen.1011268.ref045" ref-type="bibr">45</xref>,<xref rid="pgen.1011268.ref046" ref-type="bibr">46</xref>], and sexual factors are linked to sex hormones [<xref rid="pgen.1011268.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1011268.ref007" ref-type="bibr">7</xref>] which have well-established impacts on immune responses [<xref rid="pgen.1011268.ref047" ref-type="bibr">47</xref>]. Future work is warranted to fully uncover specific pathways that underlie the UL-AFS/NSP biological associations.</p>
      <p>A non-negligible shared genetic basis, as reflected by the significant genetic correlations and clustering of cell-type-specific annotations, can either be due to pleiotropic effects (horizontal pleiotropy), causal relationship (vertical pleiotropy), or both. The 10 pleiotropic loci identified for AFS with UL as well as the 5 pleiotropic loci identified for NSP with UL reflected horizontal pleiotropy. However, it is worth noting that there is a lack of overlap between the identified pleiotropic loci and shared regions, which could be attributed to differences in the focus, scale of analysis, and the power to detect significant associations. One advantage of meta-analyzing GWASs of different traits is that combining association evidence across multiple studies can reveal signals which might not have reached genome-wide significance in a single-trait analysis. Indeed, we identified 7 novel loci to jointly affect AFS/NSP and UL, among which we highlight three interesting examples, <italic toggle="yes">FZD7</italic>, <italic toggle="yes">CELF2</italic>, and <italic toggle="yes">TNNI3K</italic>.</p>
      <p>Harboring the most significant novel SNP shared between AFS and UL, <italic toggle="yes">FZD7</italic> encodes a seven-pass transmembrane wnt (Wingless/Integrated) receptor which plays an essential role in the development of various tumors [<xref rid="pgen.1011268.ref048" ref-type="bibr">48</xref>]. However, the involvement of <italic toggle="yes">FZD7</italic> in UL has rarely been studied. By interacting with <italic toggle="yes">SIRT1</italic>, a gene that regulates steroid hormone receptor activity, <italic toggle="yes">FZD7</italic> may also participate in estrogen receptor signaling [<xref rid="pgen.1011268.ref049" ref-type="bibr">49</xref>]. Encoding a nucleocytoplasmic shuttling RNA-binding protein, <italic toggle="yes">CELF2</italic> is involved in development of the central nervous system, notably, the disruption of cortical development related to decision-making [<xref rid="pgen.1011268.ref050" ref-type="bibr">50</xref>]. <italic toggle="yes">CELF2</italic> also functions in tumor initiation and progression given its consistently reduced expression during neoplastic transformation [<xref rid="pgen.1011268.ref051" ref-type="bibr">51</xref>]. In addition, expression of <italic toggle="yes">CELF2</italic> is increased in response to T-cell signaling, suggesting its involvement in inflammatory and immune responses [<xref rid="pgen.1011268.ref052" ref-type="bibr">52</xref>]. As a novel shared locus identified for both AFS-UL and NSP-UL, <italic toggle="yes">TNNI3K</italic> encodes a troponin I interacting kinase mainly implicated in cardiac physiology (consistent with our findings that UL is highly enriched in heart and muscle-relevant cell types) [<xref rid="pgen.1011268.ref053" ref-type="bibr">53</xref>]. Several as of yet not replicated studies on carcinogenesis [<xref rid="pgen.1011268.ref054" ref-type="bibr">54</xref>], viral infection [<xref rid="pgen.1011268.ref055" ref-type="bibr">55</xref>], and obesity [<xref rid="pgen.1011268.ref056" ref-type="bibr">56</xref>] further expand the spectrum of potential roles of <italic toggle="yes">TNNI3K</italic>. Future experimental work is needed to provide more detailed functional annotation of the newly discovered loci as they related to sexual factors and UL.</p>
      <p>Contrary to the evidence observed for horizontal pleiotropy, we found no evidence of a causal relationship among these traits investigated. Interestingly, when accounting for the effect of AAM or ANM, a significant negative association of genetically predicted AFS on UL was shown, indicating a later age at first sex being a putatively protective factor of UL initiation. However, our MVMR exploration results suggest that this association is predominantly confounded or mediated by the effect of AFB, which is further supported by the results of a supplementary mediation analysis (an interpretation and discussion of the mediation results can be found in <bold><xref rid="pgen.1011268.s001" ref-type="supplementary-material">S1 Text</xref></bold>). Both AFS and AFB mark the onset of human reproductive behavior and have important implications for reproductive health. While AFB has long been associated with UL risk by epidemiological studies, for example, the inverse associations reported by the longitudinal Nurses&#x2019; Health Study II (AFB &#x2265; 25 years compared with &#x2264; 24 years: 10%-30% risk reduction; AFB &#x2265; 31 years: RR = 0.71, 95% CI = 0.64&#x2013;0.79, [<xref rid="pgen.1011268.ref057" ref-type="bibr">57</xref>,<xref rid="pgen.1011268.ref058" ref-type="bibr">58</xref>], evidence on AFS remains scarce.</p>
      <p>Leveraging genetic information, our work demonstrates that AFS alone is unlikely to pose a direct causal effect on UL initiation, which is concordant with findings by Pakiz <italic toggle="yes">et al</italic>. that AFS was not an independent predictor of UL [<xref rid="pgen.1011268.ref015" ref-type="bibr">15</xref>]. While infectious agent exposure (closely related to AFS/NSP) represents an important source of inflammatory reactions, myometrial injury, and tissue repair or regeneration believed to impact UL pathogenesis [<xref rid="pgen.1011268.ref046" ref-type="bibr">46</xref>,<xref rid="pgen.1011268.ref059" ref-type="bibr">59</xref>], based on current results we question whether intrauterine infection may contribute to the occurrence of UL, which has been a topic of debate and focus of research in the UL field [<xref rid="pgen.1011268.ref010" ref-type="bibr">10</xref>,<xref rid="pgen.1011268.ref012" ref-type="bibr">12</xref>&#x2013;<xref rid="pgen.1011268.ref014" ref-type="bibr">14</xref>, <xref rid="pgen.1011268.ref060" ref-type="bibr">60</xref>&#x2013;<xref rid="pgen.1011268.ref063" ref-type="bibr">63</xref>]. Nonetheless, although we have used genetic associations as proxies for AFS and NSP, direct investigations on reproductive tract infections or pelvic inflammation are limited which may have precluded interpretation of our findings.</p>
      <p>The key strengths of this study include the largest combination of available datasets, the employment of multiple analytic frameworks to investigate the genetic-based association, and the use of both two-sample and one-sample MR designs to assess the causal effects of sexual factors on UL risk. However, we also acknowledge potential limitations. First, as our results were restricted to samples of European ancestry, generalizability to other ancestry groups is precluded. Studies leveraging large-scale GWAS that encompass different ancestries are required to understand better the genetic associations across diverse populations. Second, although we have carefully selected genetic instruments that show strong statistical associations with the exposures, common SNPs can only account for a small proportion of the overall variability observed in complex traits. This limitation is particularly evident in the case of behavioral factors such as AFS and NSP, which are influenced by a multitude of factors, including environmental, demographic, and genetic factors, as well as their intricate interactions [<xref rid="pgen.1011268.ref019" ref-type="bibr">19</xref>]. To obtain a more comprehensive understanding of how genetics and the environment jointly shape sexual behaviors and their potential impact on UL, future research integrating genetic analyses with robust environmental assessments is needed. Third, we conducted our primary analyses using sex-combined GWAS summary data of NSP, which may introduce sex heterogeneity. However, the high magnitude of genetic correlation (<italic toggle="yes">r<sub>g</sub></italic> = 0.82) between the sex-specific GWASs of the general risk tolerance measure [<xref rid="pgen.1011268.ref019" ref-type="bibr">19</xref>] has largely justified the approach of pooling males and females to maximize statistical power; furthermore, global genetic correlation and two-sample MR analyses using female-specific summary statistics for NSP (non-formal publication; <ext-link xlink:href="http://www.nealelab.is/uk-biobank/" ext-link-type="uri">http://www.nealelab.is/uk-biobank/</ext-link>) yielded largely consistent results (<italic toggle="yes">r<sub>g</sub></italic> = 0.03, <italic toggle="yes">P</italic> = 0.50; NSP to UL: OR<sub>IVW</sub> = 0.88, <italic toggle="yes">P</italic> = 0.50; UL to NSP: OR<sub>IVW</sub> = 1.01, <italic toggle="yes">P</italic> = 0.50), as in our one-sample MR analysis restricting to UK Biobank female participants. Future investigations leveraging sex-specific summary-level data are needed to validate our findings. Fourth, a considerable proportion of sample overlap may exist among the GWAS datasets used in the current study. However, the genetic approaches (i.e., LDSC, SUPERGNOVA, CPASSOC) we applied are not subject to bias introduced by sample overlap, and any bias caused by sample overlap in two-sample MR may falsely lead to a significant association, which was not observed in our analysis. Future validation using independent datasets is warranted. Moreover, we acknowledge that our study&#x2019;s definition of AFS and NSP, based on the UK Biobank data, includes a broad range of sexual experiences. This lack of specificity regarding the type and context of sexual activity may limit our understanding of the nuanced variations in risk associated with different sexual behaviors. Future research should explore more specifically defined AFS and NSP to assess their impact on the risk of UL and other relevant outcomes. It is also important to acknowledge the sensitive nature of our work and to emphasize that our intent is to contribute to a larger body of literature aimed at promoting positive health outcomes for women. Stigmatization or judgment of individual sexual behavior has no place in research. To optimize statistical power, our study, as well as the previous UL GWAS [<xref rid="pgen.1011268.ref016" ref-type="bibr">16</xref>], incorporated UL cases that were ascertained through self-report, introducing the possibility of recall bias in outcome definition. At last, we did not investigate UL subtypes based on molecular characteristics or clinical factors (e.g., location, multiplicity, and size) due to limited well-powered GWAS available for these traits. Given that previous research has identified various associations of AFS with singular or multiple UL occurences [<xref rid="pgen.1011268.ref015" ref-type="bibr">15</xref>,<xref rid="pgen.1011268.ref064" ref-type="bibr">64</xref>], future subtype-specific GWASs are needed to extend our findings.</p>
    </sec>
    <sec sec-type="conclusions" id="sec020">
      <title>Conclusions</title>
      <p>To conclude, leveraging large-scale genetic variation data for each trait, our study demonstrates a biological link underlying sexual factors (AFS and NSP) and UL. From a genetic perspective, sexual factors are not likely to elevate the risk of UL, but rather overlapping biological mechanisms underlie the relationship between these phenotypes. Future studies are needed to confirm our findings, and to elucidate the specific mechanisms involved in the shared genetic influences and their potential impact on UL development.</p>
    </sec>
    <sec id="sec021" sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material id="pgen.1011268.s001" position="float" content-type="local-data">
        <label>S1 Text</label>
        <caption>
          <title>Supplementary methods for mediation analysis and an interpretation and discussion of the mediation analysis results.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s001.docx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s002" position="float" content-type="local-data">
        <label>S1 Fig</label>
        <caption>
          <title>Graphical representation of proposed mediation through hormone-related phenotypes in the association of sexual factors with uterine leiomyoma.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s002.docx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s003" position="float" content-type="local-data">
        <label>S2 Fig</label>
        <caption>
          <title>Clustering of cell-type-specific annotation for uterine leiomyoma, age at first sexual intercourse, and lifetime number of sexual partners over histone marks.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s003.docx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s004" position="float" content-type="local-data">
        <label>S1 Table</label>
        <caption>
          <title>Characteristics of genetic instruments identified by GWAS to be associated with age at first sexual intercourse.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s004.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s005" position="float" content-type="local-data">
        <label>S2 Table</label>
        <caption>
          <title>Characteristics of genetic instruments identified by GWAS to be associated with lifetime number of sexual partners.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s005.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s006" position="float" content-type="local-data">
        <label>S3 Table</label>
        <caption>
          <title>Characteristics of genetic instruments identified by GWAS to be associated with uterine leiomyoma.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s006.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s007" position="float" content-type="local-data">
        <label>S4 Table</label>
        <caption>
          <title>Data sources, sample sizes, number of IVs, and F-statistics.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s007.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s008" position="float" content-type="local-data">
        <label>S5 Table</label>
        <caption>
          <title>Results from local genetic correlation analysis conducted for age at first sexual intercourse and uterine leiomyoma.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s008.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s009" position="float" content-type="local-data">
        <label>S6 Table</label>
        <caption>
          <title>Results from local genetic correlation analysis conducted for lifetime number of sexual partners and uterine leiomyoma.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s009.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s010" position="float" content-type="local-data">
        <label>S7 Table</label>
        <caption>
          <title>Cell-type-specific annotations showing Bonferroni-corrected significant heritability enrichments for uterine leiomyoma, age at first sexual intercourse, and lifetime number of sexual partners.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s010.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s011" position="float" content-type="local-data">
        <label>S8 Table</label>
        <caption>
          <title>Detailed annotation of genome-wide significant SNPs identified from cross-trait meta-analysis.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s011.xlsx"/>
      </supplementary-material>
      <supplementary-material id="pgen.1011268.s012" position="float" content-type="local-data">
        <label>S9 Table</label>
        <caption>
          <title>Results of mediation Mendelian randomization analysis on sexual factors and risk of uterine leiomyoma using the &#x201C;product of coefficients&#x201D; method.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1011268.s012.xlsx"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pgen.1011268.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Stewart</surname><given-names>EA</given-names></name>, <name><surname>Cookson</surname><given-names>CL</given-names></name>, <name><surname>Gandolfo</surname><given-names>RA</given-names></name>, <name><surname>Schulze-Rath</surname><given-names>R</given-names></name>. <article-title>Epidemiology of uterine fibroids: a systematic review</article-title>. <source>BJOG</source>. <year>2017</year>;<volume>124</volume>: <fpage>1501</fpage>&#x2013;<lpage>1512</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/1471-0528.14640</pub-id>
<pub-id pub-id-type="pmid">28296146</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Marino</surname><given-names>JL</given-names></name>, <name><surname>Eskenazi</surname><given-names>B</given-names></name>, <name><surname>Warner</surname><given-names>M</given-names></name>, <name><surname>Samuels</surname><given-names>S</given-names></name>, <name><surname>Vercellini</surname><given-names>P</given-names></name>, <name><surname>Gavoni</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study</article-title>. <source>Hum Reprod</source>. <year>2004</year>;<volume>19</volume>: <fpage>2350</fpage>&#x2013;<lpage>2355</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/humrep/deh407</pub-id>
<pub-id pub-id-type="pmid">15242998</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Jaeger</surname><given-names>AB</given-names></name>, <name><surname>Gramkow</surname><given-names>A</given-names></name>, <name><surname>S&#xF8;rensen</surname><given-names>P</given-names></name>, <name><surname>Melbye</surname><given-names>M</given-names></name>, <name><surname>Adami</surname><given-names>HO</given-names></name>, <name><surname>Glimelius</surname><given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Correlates of Heterosexual Behavior Among 23&#x2013;87 Year Olds in Denmark and Sweden, 1992&#x2013;1998</article-title>. <source>Archives of Sexual Behavior</source> 2000 29:1. <year>2000</year>;<volume>29</volume>: <fpage>91</fpage>&#x2013;<lpage>106</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1023/a:1001890622358</pub-id>:1001890622358 <pub-id pub-id-type="pmid">10763431</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>AM</given-names></name>, <name><surname>Mercer</surname><given-names>CH</given-names></name>, <name><surname>Erens</surname><given-names>B</given-names></name>, <name><surname>Copas</surname><given-names>AJ</given-names></name>, <name><surname>McManus</surname><given-names>S</given-names></name>, <name><surname>Wellings</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours</article-title>. <source>Lancet</source>. <year>2001</year>;<volume>358</volume>: <fpage>1835</fpage>&#x2013;<lpage>1842</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(01)06883-0</pub-id>
<pub-id pub-id-type="pmid">11741621</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Hariri</surname><given-names>S</given-names></name>, <name><surname>Bradley</surname><given-names>H</given-names></name>, <name><surname>Gottlieb</surname><given-names>SL</given-names></name>, <name><surname>Leichliter</surname><given-names>JS</given-names></name>, <name><surname>Markowitz</surname><given-names>LE</given-names></name>. <article-title>Trends and patterns of sexual behaviors among adolescents and adults aged 14 to 59 years, United States</article-title>. <source>Sex Transm Dis</source>. <year>2015</year>;<volume>42</volume>: <fpage>20</fpage>&#x2013;<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/OLQ.0000000000000231</pub-id>
<pub-id pub-id-type="pmid">25504296</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Prasad</surname><given-names>A</given-names></name>, <name><surname>Mumford</surname><given-names>SL</given-names></name>, <name><surname>Buck Louis</surname><given-names>GM</given-names></name>, <name><surname>Ahrens</surname><given-names>KA</given-names></name>, <name><surname>Sjaarda</surname><given-names>LA</given-names></name>, <name><surname>Schliep</surname><given-names>KC</given-names></name>, <etal>et al</etal>. <article-title>Sexual activity, endogenous reproductive hormones and ovulation in premenopausal women</article-title>. <source>Horm Behav</source>. <year>2014</year>;<volume>66</volume>: <fpage>330</fpage>&#x2013;<lpage>338</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.yhbeh.2014.06.012</pub-id>
<pub-id pub-id-type="pmid">24954690</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Najmabadi</surname><given-names>S</given-names></name>, <name><surname>Schliep</surname><given-names>KC</given-names></name>, <name><surname>Simonsen</surname><given-names>SE</given-names></name>, <name><surname>Porucznik</surname><given-names>CA</given-names></name>, <name><surname>Egger</surname><given-names>MJ</given-names></name>, <name><surname>Stanford</surname><given-names>JB</given-names></name>. <article-title>Characteristics of menstrual cycles with or without intercourse in women with no known subfertility</article-title>. <source>Hum Reprod Open</source>. <year>2022</year>;<fpage>2022</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/HROPEN/HOAC039</pub-id>
<pub-id pub-id-type="pmid">36186844</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Lara</surname><given-names>LAS</given-names></name>, <name><surname>Abdo</surname><given-names>CHN</given-names></name>. <article-title>Age at Time of Initial Sexual Intercourse and Health of Adolescent Girls</article-title>. <source>J Pediatr Adolesc Gynecol</source>. <year>2016</year>;<volume>29</volume>: <fpage>417</fpage>&#x2013;<lpage>423</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jpag.2015.11.012</pub-id>
<pub-id pub-id-type="pmid">26655691</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Joffe</surname><given-names>GP</given-names></name>, <name><surname>Foxman</surname><given-names>B</given-names></name>, <name><surname>Schmidt</surname><given-names>AJ</given-names></name>, <name><surname>Farris</surname><given-names>KB</given-names></name>, <name><surname>Carter</surname><given-names>RJ</given-names></name>, <name><surname>Neumann</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Multiple partners and partner choice as risk factors for sexually transmitted disease among female college students</article-title>. <source>Sex Transm Dis</source>. <year>1992</year>;<volume>19</volume>: <fpage>272</fpage>&#x2013;<lpage>278</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/00007435-199209000-00006</pub-id>
<pub-id pub-id-type="pmid">1411843</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Faerstein</surname><given-names>E</given-names></name>, <name><surname>Szklo</surname><given-names>M</given-names></name>, <name><surname>Rosenshein</surname><given-names>NB</given-names></name>. <article-title>Risk Factors for Uterine Leiomyoma: A Practice-based Case-Control Study. II. Atherogenic Risk Factors and Potential Sources of Uterine Irritation</article-title>. <source>Am J Epidemiol</source>. <year>2001</year>;<volume>153</volume>: <fpage>11</fpage>&#x2013;<lpage>19</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/153.1.11</pub-id>
<pub-id pub-id-type="pmid">11159140</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Laughlin</surname><given-names>SK</given-names></name>, <name><surname>Schroeder</surname><given-names>JC</given-names></name>, <name><surname>Baird</surname><given-names>DD</given-names></name>. <article-title>New directions in the epidemiology of uterine fibroids</article-title>. <source>Semin Reprod Med</source>. <year>2010</year>;<volume>28</volume>: <fpage>204</fpage>&#x2013;<lpage>217</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1055/s-0030-1251477</pub-id>
<pub-id pub-id-type="pmid">20414843</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>KR</given-names></name>, <name><surname>Smith</surname><given-names>JS</given-names></name>, <name><surname>Cole</surname><given-names>SR</given-names></name>, <name><surname>Dittmer</surname><given-names>DP</given-names></name>, <name><surname>Schoenbach</surname><given-names>VJ</given-names></name>, <name><surname>Baird</surname><given-names>DD</given-names></name>. <article-title>Chlamydia trachomatis Seroprevalence and Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women</article-title>. <source>Am J Epidemiol</source>. <year>2018</year>;<volume>187</volume>: <fpage>278</fpage>&#x2013;<lpage>286</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwx231</pub-id>
<pub-id pub-id-type="pmid">28637238</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Saadatnia</surname><given-names>G</given-names></name>, <name><surname>Saremi</surname><given-names>A</given-names></name>, <name><surname>Salehian</surname><given-names>B</given-names></name>, <name><surname>Salehian</surname><given-names>P</given-names></name>. <article-title>Uterine Leiomyoma and Reproductive Tract Infections Detected by Polymerase Chain Reaction</article-title>. <source>Iran J Pathol</source>. <year>2019</year>;<volume>14</volume>: <fpage>33</fpage>&#x2013;<lpage>40</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.30699/IJP.14.1.33</pub-id>
<pub-id pub-id-type="pmid">31531099</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Kabodmehri</surname><given-names>R</given-names></name>, <name><surname>Etezadi</surname><given-names>A</given-names></name>, <name><surname>Sharami</surname><given-names>SH</given-names></name>, <name><surname>Ghanaei</surname><given-names>MM</given-names></name>, <name><surname>Hosseinzadeh</surname><given-names>F</given-names></name>, <name><surname>Heirati</surname><given-names>SFD</given-names></name>, <etal>et al</etal>. <article-title>The association between chronic endometritis and uterine fibroids</article-title>. <source>J Family Med Prim Care</source>. <year>2022</year>;<volume>11</volume>: <fpage>653</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_1470_21</pub-id>
<pub-id pub-id-type="pmid">35360819</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Pakiz</surname><given-names>M</given-names></name>, <name><surname>Potocnik</surname><given-names>U</given-names></name>, <name><surname>But</surname><given-names>I</given-names></name>. <article-title>Solitary and multiple uterine leiomyomas among Caucasian women: two different disorders?</article-title>
<source>Fertil Steril</source>. <year>2010</year>;<volume>94</volume>: <fpage>2291</fpage>&#x2013;<lpage>2295</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.12.072</pub-id>
<pub-id pub-id-type="pmid">20171624</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Gallagher</surname><given-names>CS</given-names></name>, <name><surname>M&#xE4;kinen</surname><given-names>N</given-names></name>, <name><surname>Harris</surname><given-names>HR</given-names></name>, <name><surname>Rahmioglu</surname><given-names>N</given-names></name>, <name><surname>Uimari</surname><given-names>O</given-names></name>, <name><surname>Cook</surname><given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis</article-title>. <source>Nature Communications</source> 2019 10:1. <year>2019</year>;<volume>10</volume>: <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-019-12536-4</pub-id>
<pub-id pub-id-type="pmid">31649266</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Rafnar</surname><given-names>T</given-names></name>, <name><surname>Gunnarsson</surname><given-names>B</given-names></name>, <name><surname>Stefansson</surname><given-names>OA</given-names></name>, <name><surname>Sulem</surname><given-names>P</given-names></name>, <name><surname>Ingason</surname><given-names>A</given-names></name>, <name><surname>Frigge</surname><given-names>ML</given-names></name>, <etal>et al</etal>. <article-title>Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits</article-title>. <source>Nat Commun</source>. <year>2018</year>;<fpage>9</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/S41467-018-05428-6</pub-id>
<pub-id pub-id-type="pmid">29339724</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref018">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Mills</surname><given-names>MC</given-names></name>, <name><surname>Tropf</surname><given-names>FC</given-names></name>, <name><surname>Brazel</surname><given-names>DM</given-names></name>, <name><surname>van Zuydam</surname><given-names>N</given-names></name>, <name><surname>Vaez</surname><given-names>A</given-names></name>, <name><surname>Agbessi</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour</article-title>. <source>Nature Human Behaviour</source> 2021 5:12. <year>2021</year>;<volume>5</volume>: <fpage>1717</fpage>&#x2013;<lpage>1730</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41562-021-01135-3</pub-id>
<pub-id pub-id-type="pmid">34211149</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Karlsson Linn&#xE9;r</surname><given-names>R</given-names></name>, <name><surname>Biroli</surname><given-names>P</given-names></name>, <name><surname>Kong</surname><given-names>E</given-names></name>, <name><surname>Meddens</surname><given-names>SFW</given-names></name>, <name><surname>Wedow</surname><given-names>R</given-names></name>, <name><surname>Fontana</surname><given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences</article-title>. <source>Nature Genetics</source> 2019 51:2. <year>2019</year>;<volume>51</volume>: <fpage>245</fpage>&#x2013;<lpage>257</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-018-0309-3</pub-id>
<pub-id pub-id-type="pmid">30643258</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>Z</given-names></name>, <name><surname>Hasegawa</surname><given-names>K</given-names></name>, <name><surname>Camargo</surname><given-names>CA</given-names></name>, <name><surname>Liang</surname><given-names>L</given-names></name>. <article-title>Investigating asthma heterogeneity through shared and distinct genetics: Insights from genome-wide cross-trait analysis</article-title>. <source>J Allergy Clin Immunol</source>. 2020/07/22. <year>2021</year>;<volume>147</volume>: <fpage>796</fpage>&#x2013;<lpage>807</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaci.2020.07.004</pub-id>
<pub-id pub-id-type="pmid">32693092</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name>, <name><surname>Finucane</surname><given-names>HK</given-names></name>, <name><surname>Anttila</surname><given-names>V</given-names></name>, <name><surname>Gusev</surname><given-names>A</given-names></name>, <name><surname>Day</surname><given-names>FR</given-names></name>, <name><surname>Loh</surname><given-names>P-R</given-names></name>, <etal>et al</etal>. <article-title>An atlas of genetic correlations across human diseases and traits</article-title>. <source>Nature Genetics</source> 2015 47:11. <year>2015</year>;<volume>47</volume>: <fpage>1236</fpage>&#x2013;<lpage>1241</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3406</pub-id>
<pub-id pub-id-type="pmid">26414676</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Ye</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>K</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>SUPERGNOVA: local genetic correlation analysis reveals heterogeneous etiologic sharing of complex traits</article-title>. <source>Genome Biology</source> 2021 22:1. <year>2021</year>;<volume>22</volume>: <fpage>1</fpage>&#x2013;<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/S13059-021-02478-W</pub-id>
<pub-id pub-id-type="pmid">33397451</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Finucane</surname><given-names>HK</given-names></name>, <name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name>, <name><surname>Gusev</surname><given-names>A</given-names></name>, <name><surname>Trynka</surname><given-names>G</given-names></name>, <name><surname>Reshef</surname><given-names>Y</given-names></name>, <name><surname>Loh</surname><given-names>P-R</given-names></name>, <etal>et al</etal>. <article-title>Partitioning heritability by functional annotation using genome-wide association summary statistics</article-title>. <source>Nature Genetics</source> 2015 47:11. <year>2015</year>;<volume>47</volume>: <fpage>1228</fpage>&#x2013;<lpage>1235</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3404</pub-id>
<pub-id pub-id-type="pmid">26414678</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Finucane</surname><given-names>HK</given-names></name>, <name><surname>Reshef</surname><given-names>YA</given-names></name>, <name><surname>Anttila</surname><given-names>V</given-names></name>, <name><surname>Slowikowski</surname><given-names>K</given-names></name>, <name><surname>Gusev</surname><given-names>A</given-names></name>, <name><surname>Byrnes</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types</article-title>. <source>Nature Genetics</source> 2018 50:4. <year>2018</year>;<volume>50</volume>: <fpage>621</fpage>&#x2013;<lpage>629</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-018-0081-4</pub-id>
<pub-id pub-id-type="pmid">29632380</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref025">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Zhu X</surname><given-names>T</given-names></name> F, BO T, J L, JH Y, N F, <etal>et al</etal>. <article-title>Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension</article-title>. <source>Am J Hum Genet</source>. <year>2015</year>;<volume>96</volume>: <fpage>21</fpage>&#x2013;<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.11.011</pub-id>
<pub-id pub-id-type="pmid">25500260</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Purcell</surname><given-names>S</given-names></name>, <collab>B N</collab>, <collab>K T-B</collab>, <collab>L T</collab>, <collab>MA F</collab>, <collab>D B</collab>, <etal>et al</etal>. <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source>Am J Hum Genet</source>. <year>2007</year>;<volume>81</volume>: <fpage>559</fpage>&#x2013;<lpage>575</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1086/519795</pub-id>
<pub-id pub-id-type="pmid">17701901</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Zerbino</surname><given-names>D</given-names></name>, <collab>P A</collab>, <collab>W A</collab>, <collab>MR A</collab>, <collab>D B</collab>, <collab>J B</collab>, <etal>et al</etal>. <article-title>Ensembl 2018</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>;<volume>46</volume>: <fpage>D754</fpage>&#x2013;<lpage>D761</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkx1098</pub-id>
<pub-id pub-id-type="pmid">29155950</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Y</given-names></name>, <name><surname>Quan</surname><given-names>C</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Bo</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>. <article-title>3DSNP: a database for linking human noncoding SNPs to their three-dimensional interacting genes</article-title>. <source>Nucleic Acids Res</source>. <year>2017</year>;<volume>45</volume>: <fpage>D643</fpage>&#x2013;<lpage>D649</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkw1022</pub-id>
<pub-id pub-id-type="pmid">27789693</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Burgess</surname><given-names>S</given-names></name>, <name><surname>Scott</surname><given-names>RA</given-names></name>, <name><surname>Timpson</surname><given-names>NJ</given-names></name>, <name><surname>Smith</surname><given-names>GD</given-names></name>, <name><surname>Thompson</surname><given-names>SG</given-names></name>. <article-title>Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors</article-title>. <source>Eur J Epidemiol</source>. <year>2015</year>;<volume>30</volume>: <fpage>543</fpage>&#x2013;<lpage>552</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10654-015-0011-z</pub-id>
<pub-id pub-id-type="pmid">25773750</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Davey Smith</surname><given-names>G</given-names></name>, <name><surname>Ebrahim</surname><given-names>S</given-names></name>. &#x2018;<article-title>Mendelian randomization&#x2019;: can genetic epidemiology contribute to understanding environmental determinants of disease?</article-title>
<source>Int J Epidemiol</source>. <year>2003</year>;<volume>32</volume>: <fpage>1</fpage>&#x2013;<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyg070</pub-id>
<pub-id pub-id-type="pmid">12689998</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref031">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Burgess</surname><given-names>S</given-names></name>, <name><surname>Thompson</surname><given-names>SG</given-names></name>. <article-title>Avoiding bias from weak instruments in Mendelian randomization studies</article-title>. <source>Int J Epidemiol</source>. <year>2011</year>;<volume>40</volume>: <fpage>755</fpage>&#x2013;<lpage>764</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyr036</pub-id>
<pub-id pub-id-type="pmid">21414999</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref032">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Bowden</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>GD</given-names></name>, <name><surname>Burgess</surname><given-names>S</given-names></name>. <article-title>Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression</article-title>. <source>Int J Epidemiol</source>. <year>2015</year>;<volume>44</volume>: <fpage>512</fpage>&#x2013;<lpage>525</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyv080</pub-id>
<pub-id pub-id-type="pmid">26050253</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref033">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Bowden</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>GD</given-names></name>, <name><surname>Haycock</surname><given-names>PC</given-names></name>, <name><surname>Burgess</surname><given-names>S</given-names></name>. <article-title>Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator</article-title>. <source>Genet Epidemiol</source>. <year>2016</year>;<volume>40</volume>: <fpage>304</fpage>&#x2013;<lpage>314</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/gepi.21965</pub-id>
<pub-id pub-id-type="pmid">27061298</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref034">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>MacArthur</surname><given-names>J</given-names></name>, <name><surname>Bowler</surname><given-names>E</given-names></name>, <name><surname>Cerezo</surname><given-names>M</given-names></name>, <name><surname>Gil</surname><given-names>L</given-names></name>, <name><surname>Hall</surname><given-names>P</given-names></name>, <name><surname>Hastings</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)</article-title>. <source>Nucleic Acids Res</source>. <year>2017</year>;<volume>45</volume>: <fpage>D896</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkw1133</pub-id>
<pub-id pub-id-type="pmid">27899670</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref035">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Day</surname><given-names>FR</given-names></name>, <name><surname>Thompson</surname><given-names>DJ</given-names></name>, <name><surname>Helgason</surname><given-names>H</given-names></name>, <name><surname>Chasman</surname><given-names>DI</given-names></name>, <name><surname>Finucane</surname><given-names>H</given-names></name>, <name><surname>Sulem</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk</article-title>. <source>Nat Genet</source>. <year>2017</year>;<volume>49</volume>: <fpage>834</fpage>&#x2013;<lpage>841</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3841</pub-id>
<pub-id pub-id-type="pmid">28436984</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref036">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Ruth</surname><given-names>KS</given-names></name>, <name><surname>Day</surname><given-names>FR</given-names></name>, <name><surname>Hussain</surname><given-names>J</given-names></name>, <name><surname>Mart&#xED;nez-Marchal</surname><given-names>A</given-names></name>, <name><surname>Aiken</surname><given-names>CE</given-names></name>, <name><surname>Azad</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Genetic insights into biological mechanisms governing human ovarian ageing</article-title>. <source>Nature</source>. <year>2021</year>;<volume>596</volume>: <fpage>393</fpage>&#x2013;<lpage>397</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41586-021-03779-7</pub-id>
<pub-id pub-id-type="pmid">34349265</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref037">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>EVANS</surname><given-names>P</given-names></name>, <article-title>BRUNSELL S. Uterine Fibroid Tumors: Diagnosis and Treatment</article-title>. <source>Am Fam Physician</source>. <year>2007</year>;<volume>75</volume>: <fpage>1503</fpage>&#x2013;<lpage>1508</lpage>.<pub-id pub-id-type="pmid">17555142</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref038">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Sudlow</surname><given-names>C</given-names></name>, <name><surname>Gallacher</surname><given-names>J</given-names></name>, <name><surname>Allen</surname><given-names>N</given-names></name>, <name><surname>Beral</surname><given-names>V</given-names></name>, <name><surname>Burton</surname><given-names>P</given-names></name>, <name><surname>Danesh</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age</article-title>. <source>PLoS Med</source>. <year>2015</year>;<fpage>12</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id>
<pub-id pub-id-type="pmid">25826379</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref039">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Perry</surname><given-names>JRB</given-names></name>, <name><surname>Day</surname><given-names>F</given-names></name>, <name><surname>Elks</surname><given-names>CE</given-names></name>, <name><surname>Sulem</surname><given-names>P</given-names></name>, <name><surname>Thompson</surname><given-names>DJ</given-names></name>, <name><surname>Ferreira</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche</article-title>. <source>Nature</source>. <year>2014</year>;<volume>514</volume>: <fpage>92</fpage>&#x2013;<lpage>97</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature13545</pub-id>
<pub-id pub-id-type="pmid">25231870</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref040">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Pickrell</surname><given-names>JK</given-names></name>, <name><surname>Berisa</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>JZ</given-names></name>, <name><surname>S&#xE9;gurel</surname><given-names>L</given-names></name>, <name><surname>Tung</surname><given-names>JY</given-names></name>, <name><surname>Hinds</surname><given-names>DA</given-names></name>. <article-title>Detection and interpretation of shared genetic influences on 42 human traits</article-title>. <source>Nat Genet</source>. <year>2016</year>;<volume>48</volume>: <fpage>709</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3570</pub-id>
<pub-id pub-id-type="pmid">27182965</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref041">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Kichaev</surname><given-names>G</given-names></name>, <name><surname>Bhatia</surname><given-names>G</given-names></name>, <name><surname>Loh</surname><given-names>PR</given-names></name>, <name><surname>Gazal</surname><given-names>S</given-names></name>, <name><surname>Burch</surname><given-names>K</given-names></name>, <name><surname>Freund</surname><given-names>MK</given-names></name>, <etal>et al</etal>. <article-title>Leveraging Polygenic Functional Enrichment to Improve GWAS Power</article-title>. <source>Am J Hum Genet</source>. <year>2019</year>;<volume>104</volume>: <fpage>65</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.11.008</pub-id>
<pub-id pub-id-type="pmid">30595370</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref042">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Sakaue</surname><given-names>S</given-names></name>, <name><surname>Kanai</surname><given-names>M</given-names></name>, <name><surname>Tanigawa</surname><given-names>Y</given-names></name>, <name><surname>Karjalainen</surname><given-names>J</given-names></name>, <name><surname>Kurki</surname><given-names>M</given-names></name>, <name><surname>Koshiba</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>A cross-population atlas of genetic associations for 220 human phenotypes</article-title>. <source>Nature Genetics</source> 2021 53:10. <year>2021</year>;<volume>53</volume>: <fpage>1415</fpage>&#x2013;<lpage>1424</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-021-00931-x</pub-id>
<pub-id pub-id-type="pmid">34594039</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref043">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>C</given-names></name>, <name><surname>Kraft</surname><given-names>P</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Buring</surname><given-names>JE</given-names></name>, <name><surname>Par&#xE9;</surname><given-names>G</given-names></name>, <name><surname>Hankinson</surname><given-names>SE</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association studies identify loci associated with age at menarche and age at natural menopause</article-title>. <source>Nat Genet</source>. <year>2009</year>;<volume>41</volume>: <fpage>724</fpage>&#x2013;<lpage>728</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.385</pub-id>
<pub-id pub-id-type="pmid">19448621</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref044">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>Stolk</surname><given-names>L</given-names></name>, <name><surname>Perry</surname><given-names>JRB</given-names></name>, <name><surname>Chasman</surname><given-names>DI</given-names></name>, <name><surname>He</surname><given-names>C</given-names></name>, <name><surname>Mangino</surname><given-names>M</given-names></name>, <name><surname>Sulem</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways</article-title>. <source>Nat Genet</source>. <year>2012</year>;<volume>44</volume>: <fpage>260</fpage>&#x2013;<lpage>268</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.1051</pub-id>
<pub-id pub-id-type="pmid">22267201</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref045">
        <label>45</label>
        <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Ciebiera</surname><given-names>M</given-names></name>, <name><surname>Bariani</surname><given-names>MV</given-names></name>, <name><surname>Ali</surname><given-names>M</given-names></name>, <name><surname>Elkafas</surname><given-names>H</given-names></name>, <name><surname>Boyer</surname><given-names>TG</given-names></name>, <etal>et al</etal>. <article-title>Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment</article-title>. <source>Endocr Rev</source>. <year>2022</year>;<volume>43</volume>: <fpage>678</fpage>&#x2013;<lpage>719</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1210/endrev/bnab039</pub-id>
<pub-id pub-id-type="pmid">34741454</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref046">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>Wegienka</surname><given-names>G.</given-names></name>
<article-title>Are uterine leiomyoma a consequence of a chronically inflammatory immune system?</article-title>
<source>Med Hypotheses</source>. <year>2012</year>;<volume>79</volume>: <fpage>226</fpage>&#x2013;<lpage>231</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.mehy.2012.04.046</pub-id>
<pub-id pub-id-type="pmid">22608860</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref047">
        <label>47</label>
        <mixed-citation publication-type="journal"><name><surname>Bouman</surname><given-names>A</given-names></name>, <name><surname>Jan Heineman</surname><given-names>M</given-names></name>, <name><surname>Faas</surname><given-names>MM</given-names></name>. <article-title>Sex hormones and the immune response in humans</article-title>. <source>Hum Reprod Update</source>. <year>2005</year>;<volume>11</volume>: <fpage>411</fpage>&#x2013;<lpage>423</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/humupd/dmi008</pub-id>
<pub-id pub-id-type="pmid">15817524</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref048">
        <label>48</label>
        <mixed-citation publication-type="journal"><name><surname>Qiu</surname><given-names>X</given-names></name>, <name><surname>Jiao</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Tian</surname><given-names>T</given-names></name>. <article-title>Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ</article-title>. <source>Oncotarget</source>. <year>2016</year>;<volume>7</volume>: <fpage>85987</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.18632/oncotarget.13292</pub-id>
<pub-id pub-id-type="pmid">27852064</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref049">
        <label>49</label>
        <mixed-citation publication-type="journal"><name><surname>Simmons</surname><given-names>GE</given-names></name>, <name><surname>Pandey</surname><given-names>S</given-names></name>, <name><surname>Nedeljkovic-Kurepa</surname><given-names>A</given-names></name>, <name><surname>Saxena</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>A</given-names></name>, <name><surname>Pruitt</surname><given-names>K</given-names></name>. <article-title>Frizzled 7 Expression Is Positively Regulated by SIRT1 and &#x3B2;-Catenin in Breast Cancer Cells</article-title>. <source>PLoS One</source>. <year>2014</year>;<fpage>9</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0098861</pub-id>
<pub-id pub-id-type="pmid">24897117</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref050">
        <label>50</label>
        <mixed-citation publication-type="journal"><name><surname>Itai</surname><given-names>T</given-names></name>, <name><surname>Hamanaka</surname><given-names>K</given-names></name>, <name><surname>Sasaki</surname><given-names>K</given-names></name>, <name><surname>Wagner</surname><given-names>M</given-names></name>, <name><surname>Kotzaeridou</surname><given-names>U</given-names></name>, <name><surname>Br&#xF6;sse</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy</article-title>. <source>Hum Mutat</source>. <year>2021</year>;<volume>42</volume>: <fpage>66</fpage>&#x2013;<lpage>76</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/humu.24130</pub-id>
<pub-id pub-id-type="pmid">33131106</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref051">
        <label>51</label>
        <mixed-citation publication-type="journal"><collab>S R</collab>, <collab>P R</collab>, <collab>D S</collab>, <collab>S A</collab>. <article-title>Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer</article-title>. <source>Immunogastroenterology</source>. <year>2012</year>;<volume>1</volume>: <fpage>27</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7178/ig.1.1.7</pub-id>
<pub-id pub-id-type="pmid">23795348</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref052">
        <label>52</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Guo</surname><given-names>C</given-names></name>, <name><surname>Jiao</surname><given-names>D</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis</article-title>. <source>J Cell Mol Med</source>. <year>2021</year>;<volume>25</volume>: <fpage>7559</fpage>&#x2013;<lpage>7574</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/jcmm.16791</pub-id>
<pub-id pub-id-type="pmid">34288370</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref053">
        <label>53</label>
        <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>C</given-names></name>, <name><surname>Mu&#xF1;oz-mart&#xED;n</surname><given-names>N</given-names></name>, <name><surname>Lodder</surname><given-names>EM</given-names></name>. <article-title>The Diverse Roles of TNNI3K in Cardiac Disease and Potential for Treatment</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<fpage>22</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/IJMS22126422</pub-id>
<pub-id pub-id-type="pmid">35008458</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref054">
        <label>54</label>
        <mixed-citation publication-type="journal"><name><surname>Yeh</surname><given-names>CN</given-names></name>, <name><surname>Chen</surname><given-names>MH</given-names></name>, <name><surname>Chang</surname><given-names>YC</given-names></name>, <name><surname>Wu</surname><given-names>RC</given-names></name>, <name><surname>Tsao</surname><given-names>LC</given-names></name>, <name><surname>Wang</surname><given-names>SY</given-names></name>, <etal>et al</etal>. <article-title>Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma</article-title>. <source>Mol Carcinog</source>. <year>2019</year>;<volume>58</volume>: <fpage>270</fpage>&#x2013;<lpage>278</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/mc.22925</pub-id>
<pub-id pub-id-type="pmid">30334579</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref055">
        <label>55</label>
        <mixed-citation publication-type="journal"><name><surname>Wiltshire</surname><given-names>SA</given-names></name>, <name><surname>Leiva-Torres</surname><given-names>GA</given-names></name>, <name><surname>Vidal</surname><given-names>SM</given-names></name>. <article-title>Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of Tnni3k, Fpgt, or H28 control susceptibility to viral myocarditis</article-title>. <source>J Immunol</source>. <year>2011</year>;<volume>186</volume>: <fpage>6398</fpage>&#x2013;<lpage>6405</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4049/jimmunol.1100159</pub-id>
<pub-id pub-id-type="pmid">21525387</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref056">
        <label>56</label>
        <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Bradfield</surname><given-names>JP</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Sleiman</surname><given-names>PM</given-names></name>, <name><surname>Kim</surname><given-names>CE</given-names></name>, <name><surname>Glessner</surname><given-names>JT</given-names></name>, <etal>et al</etal>. <article-title>Role of BMI-Associated Loci Identified in GWAS Meta-Analyses in the Context of Common Childhood Obesity in European Americans</article-title>. <source>Obesity</source>. <year>2011</year>;<volume>19</volume>: <fpage>2436</fpage>&#x2013;<lpage>2439</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/oby.2011.237</pub-id>
<pub-id pub-id-type="pmid">21779088</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref057">
        <label>57</label>
        <mixed-citation publication-type="journal"><name><surname>Marshall</surname><given-names>LM</given-names></name>, <name><surname>Spiegelman</surname><given-names>D</given-names></name>, <name><surname>Goldman</surname><given-names>MB</given-names></name>, <name><surname>Manson</surname><given-names>JAE</given-names></name>, <name><surname>Colditz</surname><given-names>GA</given-names></name>, <name><surname>Barbieri</surname><given-names>RL</given-names></name>, <etal>et al</etal>. <article-title>A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata</article-title>. <source>Fertil Steril</source>. <year>1998</year>;<volume>70</volume>: <fpage>432</fpage>&#x2013;<lpage>439</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0015-0282(98)00208-8</pub-id>
<pub-id pub-id-type="pmid">9757871</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref058">
        <label>58</label>
        <mixed-citation publication-type="journal"><name><surname>Terry</surname><given-names>KL</given-names></name>, <name><surname>De Vivo</surname><given-names>I</given-names></name>, <name><surname>Hankinson</surname><given-names>SE</given-names></name>, <name><surname>Missmer</surname><given-names>SA</given-names></name>. <article-title>Reproductive characteristics and risk of uterine leiomyomata</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>94</volume>: <fpage>2703</fpage>&#x2013;<lpage>2707</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.fertnstert.2010.04.065</pub-id>
<pub-id pub-id-type="pmid">20627243</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref059">
        <label>59</label>
        <mixed-citation publication-type="journal"><name><surname>Leppert</surname><given-names>PC</given-names></name>, <name><surname>Catherino</surname><given-names>WH</given-names></name>, <name><surname>Segars</surname><given-names>JH</given-names></name>. <article-title>A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays</article-title>. <source>Am J Obstet Gynecol</source>. <year>2006</year>;<volume>195</volume>: <fpage>415</fpage>&#x2013;<lpage>420</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajog.2005.12.059</pub-id>
<pub-id pub-id-type="pmid">16635466</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref060">
        <label>60</label>
        <mixed-citation publication-type="journal"><name><surname>Stewart</surname><given-names>EA</given-names></name>, <name><surname>Nowak</surname><given-names>RA</given-names></name>. <article-title>New concepts in the treatment of uterine leiomyomas</article-title>. <source>Obstetrics and Gynecology</source>. <year>1998</year>;<volume>92</volume>: <fpage>624</fpage>&#x2013;<lpage>627</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0029-7844(98)00243-9</pub-id>
<pub-id pub-id-type="pmid">9764641</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref061">
        <label>61</label>
        <mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>KR</given-names></name>, <name><surname>Cole</surname><given-names>SR</given-names></name>, <name><surname>Dittmer</surname><given-names>DP</given-names></name>, <name><surname>Schoenbach</surname><given-names>VJ</given-names></name>, <name><surname>Smith</surname><given-names>JS</given-names></name>, <name><surname>Baird</surname><given-names>DD</given-names></name>. <article-title>Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women</article-title>. <source>J Womens Health (Larchmt)</source>. <year>2015</year>;<volume>24</volume>: <fpage>489</fpage>&#x2013;<lpage>495</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1089/jwh.2014.5051</pub-id>
<pub-id pub-id-type="pmid">25901468</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref062">
        <label>62</label>
        <mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>KR</given-names></name>, <name><surname>Harmon</surname><given-names>QE</given-names></name>, <name><surname>Baird</surname><given-names>DD</given-names></name>. <article-title>Herpes Simplex Virus Type 2 Seroprevalence and Incidence and Growth of Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women</article-title>. <source>Am J Epidemiol</source>. <year>2021</year>;<volume>190</volume>: <fpage>2158</fpage>&#x2013;<lpage>2162</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwab160</pub-id>
<pub-id pub-id-type="pmid">34038935</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref063">
        <label>63</label>
        <mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>K</given-names></name>, <name><surname>Baird</surname><given-names>D</given-names></name>. <article-title>Genital Chlamydia trachomatis Seroprevalence and Uterine Fibroid Development: Cohort Study of Young African-American Women</article-title>. <source>Microorganisms</source>. <year>2022</year>;<fpage>10</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/MICROORGANISMS10010010</pub-id>
<pub-id pub-id-type="pmid">36677302</pub-id>
</mixed-citation>
      </ref>
      <ref id="pgen.1011268.ref064">
        <label>64</label>
        <mixed-citation publication-type="journal"><name><surname>Krsteski</surname><given-names>J</given-names></name>, <name><surname>Jurgec</surname><given-names>S</given-names></name>, <name><surname>Paki&#x17E;</surname><given-names>M</given-names></name>, <name><surname>But</surname><given-names>I</given-names></name>, <name><surname>Poto&#x10D;nik</surname><given-names>U</given-names></name>. <article-title>Polymorphism of the IL13 gene may be associated with Uterine leiomyomas in Slovenian women</article-title>. <source>Balkan J Med Genet</source>. <year>2017</year>;<volume>19</volume>: <fpage>51</fpage>&#x2013;<lpage>59</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1515/bjmg-2016-0036</pub-id>
<pub-id pub-id-type="pmid">28289589</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="aggregated-review-documents" id="pgen.1011268.r001" specific-use="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1011268.r001</article-id>
      <title-group>
        <article-title>Decision Letter 0</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Scott M.</given-names>
          </name>
          <role>Section Editor</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>Digna Velez</given-names>
          </name>
          <role>Guest Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Williams, Edwards</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Williams, Edwards</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1011268" id="rel-obj001" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>0</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">29 Nov 2023</named-content>
</p>
      <p>Dear Dr Wu,</p>
      <p>Thank you very much for submitting your Research Article entitled 'A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma' to PLOS Genetics.</p>
      <p>The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time. One major concern that requires attention is the critique by reviewer 2 that questions&#xA0;the use of a genetic instrument to study this problem.&#xA0;</p>
      <p>Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.</p>
      <p>If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to <email>plosgenetics@plos.org</email>.</p>
      <p>If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our&#xA0;<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist" ext-link-type="uri">Submission Checklist</ext-link>.</p>
      <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
      <p>Please be aware that our&#xA0;<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link>&#xA0;requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.</p>
      <p>While revising your submission, please upload your figure files to the&#xA0;<ext-link xlink:href="http://pace.apexcovantage.com/" ext-link-type="uri">Preflight Analysis and Conversion Engine</ext-link>&#xA0;(PACE) digital diagnostic tool.&#xA0; PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p>
      <p>PLOS has incorporated&#xA0;<ext-link xlink:href="http://www.crossref.org/crosscheck.html" ext-link-type="uri">Similarity Check</ext-link>, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.</p>
      <p>To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.</p>
      <p>We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.</p>
      <p>Yours sincerely,</p>
      <p>Digna Velez Edwards</p>
      <p>Guest Editor</p>
      <p>PLOS Genetics</p>
      <p>Scott Williams</p>
      <p>Section Editor</p>
      <p>PLOS Genetics</p>
      <p>Please address the concerns regarding the use of genetics for traits determined by environment for this type of study and methodologic concerns.</p>
      <p>Reviewer's Responses to Questions</p>
      <p>
<bold>Comments to the Authors:</bold>
</p>
      <p>
<bold>Please note here if the review is uploaded as an attachment.</bold>
</p>
      <p>Reviewer #1:&#xA0;This is a well-written manuscript that explores genome-wide and local genetic correlations between uterine leiomyoma (UL) and two sexual factors: age at first sexual intercourse (AFS) and lifetime number of sexual partners (NSP). The study was carried out using GWAS summary data from European-ancestry cohorts as well as individual-data from the UK Biobank to conduct Mendelian randomization (MR).</p>
      <p>I have the following questions/comments:</p>
      <p>1.) A significant negative genome-wide correlation was found between AFS and UL. In addition, four significant local genetic correlations were identified between these two traits. Do these local correlations have the same direction (i.e., negative) as the genome-wide correlation?</p>
      <p>2.) Could the authors speculate a little bit in the discussion about the shared immune and blood-related components between UL with AFS and NSP?</p>
      <p>3) Please specify if the pleiotropic AFS/UL SNPs in Table 1 are in the same genomic regions with significant local genetic correlations between AFS and UL. If that is not the case, please speculate why.</p>
      <p>Reviewer #2:&#xA0;The review is uploaded as an attachment.</p>
      <p>Reviewer #3:&#xA0;Thank you for this thorough analysis and exploration of sexual factors and UL. I appreciated the complementary approaches taken for this analysis and the summary of methods shown in Figure 1.</p>
      <p>Please provide sample sizes for subgroups of pre- and post-menopausal women.</p>
      <p>It is mentioned that the observed association between AFS and UL may be confounded by AFB. For future research, consider a mediation analysis to analyze the pathway AFS --&gt; AFB --&gt; UL.</p>
      <p>Typos:</p>
      <p>p. 4, lines 105-106; please keep the verbs in the same tense (past or present)</p>
      <p>p. 8, lines 207; &#x201C;&#x2026; adjust for potential confounding effect&#x2026;&#x201D; should be &#x201C;to adjust for any potential confounding effects&#x2026;&#x201D;</p>
      <p>p. 15, line 408; &#x201C;well-power&#x201D; should be &#x201C;well-powered&#x201D;</p>
      <p>Figure 1: The box &#x201C;Pleiotropic effect and casual relaitonship identification&#x201D; should be &#x201C;Pleiotropic effect and causal relationship identification&#x201D;</p>
      <p>**********</p>
      <p>
<bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
</p>
      <p>Large-scale datasets should be made available via a public repository as described in the <italic toggle="yes">PLOS Genetics</italic>
<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>Reviewer #3:&#xA0;Yes</p>
      <p>**********</p>
      <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
      <p>If you choose &#x201C;no&#x201D;, your identity will remain anonymous but your review may still be made public.</p>
      <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
      <p>Reviewer #1:&#xA0;No</p>
      <p>Reviewer #2:&#xA0;No</p>
      <p>Reviewer #3:&#xA0;No</p>
      <supplementary-material id="pgen.1011268.s013" position="float" content-type="local-data">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">PGENETICS-D-23-01080.docx</named-content></p>
        </caption>
        <media xlink:href="pgen.1011268.s013.docx"/>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article article-type="author-comment" id="pgen.1011268.r002">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1011268.r002</article-id>
      <title-group>
        <article-title>Author response to Decision Letter 0</article-title>
      </title-group>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1011268" id="rel-obj002" related-article-type="editor-report"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="author-response-date">29 Jan 2024</named-content>
</p>
      <supplementary-material id="pgen.1011268.s014" position="float" content-type="local-data">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p>
        </caption>
        <media xlink:href="pgen.1011268.s014.docx"/>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article article-type="aggregated-review-documents" id="pgen.1011268.r003" specific-use="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1011268.r003</article-id>
      <title-group>
        <article-title>Decision Letter 1</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Scott M.</given-names>
          </name>
          <role>Section Editor</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>Digna Velez</given-names>
          </name>
          <role>Guest Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Williams, Edwards</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Williams, Edwards</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1011268" id="rel-obj003" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">19 Mar 2024</named-content>
</p>
      <p>Dear Dr Wu,</p>
      <p>Thank you very much for submitting your Research Article entitled 'A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma' to PLOS Genetics.</p>
      <p>The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript.</p>
      <p>We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.</p>
      <p>In addition we ask that you:</p>
      <p>1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.</p>
      <p>2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our&#xA0;<ext-link xlink:href="https://journals.plos.org/plosgenetics/volume" ext-link-type="uri">archive</ext-link>. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.</p>
      <p>We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to <email>plosgenetics@plos.org</email>.</p>
      <p>If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our&#xA0;<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist" ext-link-type="uri">Submission Checklist</ext-link>.</p>
      <p>While revising your submission, please upload your figure files to the&#xA0;<ext-link xlink:href="http://pace.apexcovantage.com/" ext-link-type="uri">Preflight Analysis and Conversion Engine</ext-link>&#xA0;(PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p>
      <p>Please be aware that our&#xA0;<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link>&#xA0;requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.</p>
      <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
      <p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.&#xA0;If you need to cite a retracted article, indicate the article&#x2019;s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
      <p>PLOS has incorporated&#xA0;<ext-link xlink:href="http://www.crossref.org/crosscheck.html" ext-link-type="uri">Similarity Check</ext-link>, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.</p>
      <p>To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.</p>
      <p>Please let us know if you have any questions while making these revisions.</p>
      <p>Yours sincerely,</p>
      <p>Digna Velez Edwards</p>
      <p>Guest Editor</p>
      <p>PLOS Genetics</p>
      <p>Scott Williams</p>
      <p>Section Editor</p>
      <p>PLOS Genetics</p>
      <p>Reviewer's Responses to Questions</p>
      <p>
<bold>Comments to the Authors:</bold>
</p>
      <p>
<bold>Please note here if the review is uploaded as an attachment.</bold>
</p>
      <p>Reviewer #1:&#xA0;I appreciate the authors for addressing all of my comments. The manuscript has greatly improved after these changes.</p>
      <p>Reviewer #3:&#xA0;Thank you for your careful attention to the suggestions made.</p>
      <p>Please include a brief paragraph in the Methods section about the mediation analysis.</p>
      <p>Reviewer #4:&#xA0;The authors have conducted a well thought out study and made significant improvements to the manuscript with the revised changes. I have some follow up questions/comments for them to consider.</p>
      <p>1. In the one-sample MR analysis for post-menopausal females, did the authors exclude individuals who had a hysterectomy?</p>
      <p>2. The authors state that none of the risk factors investigated in the mediation analysis showed supporting evidence as mediators, but then they also say that they observed a significant indirect effect of AFS on UL through AFB. It is unclear to me how they came to this conclusion when several of the potential mediators they analyzed had indirect effects with a p-value &lt; 0.05. Please clarify.</p>
      <p>3. The authors should explain what significance threshold they used for the mediation and MR analyses. They should also consider whether a Bonferroni correction should be applied due to the number of tests performed in their analysis.</p>
      <p>4. The methods for the mediation analysis are not described. It would be helpful to understand how the hormone datasets were made since participants in the UK Biobank were recruited between ages 40 to 69. Hormone levels can change with age and the traits being studied can occur at different periods throughout an individual&#x2019;s life. Do the authors have any thoughts on if this could influence the results?</p>
      <p>5. UK Biobank data was used for both the UL and sexual factors GWAS. Having overlapping samples in the two-sample MR analysis when non-overlapping samples are required, could greatly bias the results. Although this was briefly discussed as a limitation, considering the impact of this, it should be thoroughly addressed. Did the authors explore any ways to avoid this, such as by using a leave-one-out analysis for the UL GWAS or using an independent dataset?</p>
      <p>**********</p>
      <p>
<bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
</p>
      <p>Large-scale datasets should be made available via a public repository as described in the <italic toggle="yes">PLOS Genetics</italic>
<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>Reviewer #3:&#xA0;Yes</p>
      <p>Reviewer #4:&#xA0;Yes</p>
      <p>**********</p>
      <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
      <p>If you choose &#x201C;no&#x201D;, your identity will remain anonymous but your review may still be made public.</p>
      <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
      <p>Reviewer #1:&#xA0;No</p>
      <p>Reviewer #3:&#xA0;No</p>
      <p>Reviewer #4:&#xA0;No</p>
    </body>
  </sub-article>
  <sub-article article-type="author-comment" id="pgen.1011268.r004">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1011268.r004</article-id>
      <title-group>
        <article-title>Author response to Decision Letter 1</article-title>
      </title-group>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1011268" id="rel-obj004" related-article-type="editor-report"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>2</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="author-response-date">3 Apr 2024</named-content>
</p>
      <supplementary-material id="pgen.1011268.s015" position="float" content-type="local-data">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p>
        </caption>
        <media xlink:href="pgen.1011268.s015.docx"/>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article article-type="editor-report" id="pgen.1011268.r005" specific-use="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1011268.r005</article-id>
      <title-group>
        <article-title>Decision Letter 2</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Scott M.</given-names>
          </name>
          <role>Section Editor</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>Digna Velez</given-names>
          </name>
          <role>Guest Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Williams, Edwards</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Williams, Edwards</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1011268" id="rel-obj005" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>2</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">22 Apr 2024</named-content>
</p>
      <p>Dear Dr Wu,</p>
      <p>We are pleased to inform you that your manuscript entitled "A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma" has been editorially accepted for publication in PLOS Genetics. Congratulations!</p>
      <p>Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.</p>
      <p>Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you&#x2019;ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <email>plosgenetics@plos.org</email>.</p>
      <p>In the meantime, please log into Editorial Manager at <ext-link xlink:href="https://www.editorialmanager.com/pgenetics/" ext-link-type="uri">https://www.editorialmanager.com/pgenetics/</ext-link>, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process.&#xA0;Note that&#xA0;PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to &#x2018;Update my Information&#x2019; (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.&#xA0; This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.</p>
      <p>If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.</p>
      <p>Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!</p>
      <p>Yours sincerely,</p>
      <p>Digna Velez Edwards</p>
      <p>Guest Editor</p>
      <p>PLOS Genetics</p>
      <p>Scott Williams</p>
      <p>Section Editor</p>
      <p>PLOS Genetics</p>
      <p>
<ext-link xlink:href="http://www.plosgenetics.org" ext-link-type="uri">www.plosgenetics.org</ext-link>
</p>
      <p>Twitter: @PLOSGenetics</p>
      <p>----------------------------------------------------</p>
      <p>Comments from the reviewers (if applicable):</p>
      <p>----------------------------------------------------</p>
      <p>
<bold>Data Deposition</bold>
</p>
      <p>If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the&#xA0;<ext-link xlink:href="http://www.datadryad.org/" ext-link-type="uri">Dryad Digital Repository</ext-link>. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our&#xA0;<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability#loc-recommended-repositories" ext-link-type="uri">website</ext-link>.</p>
      <p>The following link will take you to the Dryad record for your article, so you won't have to re&#x2010;enter its bibliographic information, and can upload your files directly:&#xA0;</p>
      <p>
<ext-link xlink:href="http://datadryad.org/submit?journalID=pgenetics&amp;manu=PGENETICS-D-23-01080R2" ext-link-type="uri">http://datadryad.org/submit?journalID=pgenetics&amp;manu=PGENETICS-D-23-01080R2</ext-link>
</p>
      <p>More information about depositing data in Dryad is available at <ext-link xlink:href="http://www.datadryad.org/depositing" ext-link-type="uri">http://www.datadryad.org/depositing</ext-link>. If you experience any difficulties in submitting your data, please contact <email>help@datadryad.org</email> for support.</p>
      <p>Additionally, please be aware that our&#xA0;<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link>&#xA0;requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.</p>
      <p>----------------------------------------------------</p>
      <p>
<bold>Press Queries</bold>
</p>
      <p>If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via <email>plosgenetics@plos.org</email>.</p>
    </body>
  </sub-article>
  <sub-article article-type="editor-report" id="pgen.1011268.r006" specific-use="acceptance-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1011268.r006</article-id>
      <title-group>
        <article-title>Acceptance letter</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Scott M.</given-names>
          </name>
          <role>Section Editor</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>Digna Velez</given-names>
          </name>
          <role>Guest Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Williams, Edwards</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Williams, Edwards</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1011268" id="rel-obj006" related-article-type="reviewed-article"/>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">29 Apr 2024</named-content>
</p>
      <p>PGENETICS-D-23-01080R2 </p>
      <p>A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma </p>
      <p>Dear Dr Wu, </p>
      <p>We are pleased to inform you that your manuscript entitled "A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
      <p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
      <p>Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
      <p>Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work! </p>
      <p>With kind regards,</p>
      <p>Zsofia Freund</p>
      <p>PLOS Genetics</p>
      <p>On behalf of:</p>
      <p>The PLOS Genetics Team</p>
      <p>Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom</p>
      <p><email>plosgenetics@plos.org</email> | +44 (0) 1223-442823</p>
      <p><ext-link xlink:href="http://plosgenetics.org" ext-link-type="uri">plosgenetics.org</ext-link> | Twitter: @PLOSGenetics</p>
    </body>
  </sub-article>
</article>
</pmc-articleset>